hg_144932.1

Basic information about the TSS

---

TSS ID: hg_144932.1 Species: human Chr: chr14		Start: 100375402 End: 100375413 Strand: -
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: M61715 Distance: 12 GeneID: 7453 HGNC/MGI_ID: HGNC:12729 UniProt_ID:

Gene_name: tryptophanyl-tRNA synthetase 1 Gene_symbol: WARS1 Gene_synonyms: IFP53 Gene_source: HGNC:12729

TATA-Box annotation

---

Distance to TSS:	-61
Nearest PromoterID:	NM_213646
Entrez ID:	7453
Nearest Unigene:	Hs.497599
Nearest Refseq:	NM_004184
Nearest Ensembl:	ENSG00000140105
Gene Name:	tryptophanyl-tRNA synthetase 1
Gene Alias:	GAMMA-2|HMN9|IFI53|IFP53
Gene Description:	tryptophanyl-tRNA synthetase
Gene Type:	protein-coding
CpG%:	0.01
GC%:	0.477612
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):	28(GAGTATTAAAGA,-,0.00)

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@WARS1 p2@WARS1 p3@WARS1 p4@WARS1 p5@WARS1 p6@WARS1 p7@WARS1 p8@WARS1 p9@WARS1 p10@WARS1
Sample		p1@WARS1	p2@WARS1	p3@WARS1	p4@WARS1	p5@WARS1	p6@WARS1	p7@WARS1	p8@WARS1	p9@WARS1	p10@WARS1
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	0.19	31.56	1.17	0.00	0.00	0.19	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	0.20	35.61	0.81	0.20	0.00	0.20	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	0.00	32.21	0.96	0.00	0.00	0.00	0.00	0.00	0.39	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	3.74	30.35	1.04	0.21	0.00	0.42	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	2.92	29.02	1.35	0.45	0.22	0.22	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	5.43	32.56	1.36	0.19	0.00	0.00	0.00	0.19	0.19	0.00
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	53.16	61.44	2.40	0.65	0.22	0.44	0.00	0.00	0.65	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	47.72	55.95	1.45	0.24	0.24	0.00	0.00	0.00	0.24	0.00
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	46.80	54.07	2.99	0.21	0.21	0.00	0.00	0.00	0.00	0.21
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	52.17	60.86	12.17	1.74	1.74	1.74	0.00	0.00	0.58	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	45.68	60.23	12.53	2.43	0.00	0.40	0.00	0.00	0.81	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	43.09	63.42	10.16	4.07	0.00	2.03	0.00	0.41	0.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	0.00	11.61	1.13	0.32	0.00	0.00	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	0.30	13.83	1.05	1.05	0.00	0.15	0.00	0.15	0.15	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	0.00	10.98	0.44	0.66	0.00	0.22	0.00	0.00	0.22	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	0.50	12.32	0.25	1.01	0.25	0.25	0.00	0.25	0.25	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	0.00	11.14	1.09	0.44	0.00	0.22	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	0.00	8.44	2.53	0.00	0.00	0.42	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	0.00	6.93	0.00	1.07	0.53	0.53	0.00	0.00	0.53	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	0.15	10.83	1.35	0.15	0.00	0.15	0.00	0.00	0.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	0.53	12.83	1.60	1.07	0.13	0.27	0.00	0.13	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	0.35	13.29	1.21	0.69	0.00	0.17	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	0.26	12.41	0.90	0.65	0.13	0.39	0.13	0.13	0.13	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	0.00	13.35	1.46	0.49	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	0.26	14.96	1.81	0.52	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	0.32	13.93	1.90	1.27	0.00	0.32	0.00	0.00	0.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	0.00	14.29	1.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	1.65	16.74	3.06	1.18	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	0.81	11.31	0.81	1.29	0.00	0.32	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	0.90	14.48	2.17	1.09	0.36	0.00	0.00	0.00	0.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	6.70	14.24	2.09	1.05	0.00	0.42	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	5.47	13.29	1.95	0.78	0.20	0.39	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	5.91	20.47	2.32	1.06	0.00	0.42	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	17.15	24.41	4.45	3.13	0.49	0.33	0.33	0.00	0.16	0.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	8.04	19.07	1.68	1.12	0.19	0.56	0.19	0.00	0.19	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	9.20	16.86	2.68	0.19	0.77	0.00	0.00	0.19	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	18.80	19.21	3.47	0.61	0.00	0.41	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	21.16	17.53	2.62	1.61	0.20	0.81	0.20	0.20	0.20	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	22.42	23.77	3.24	2.70	0.00	0.54	0.00	0.00	0.54	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	32.17	19.69	4.32	1.68	0.48	0.96	0.48	0.00	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	26.58	24.23	1.65	1.65	1.18	0.00	0.24	0.00	1.18	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	35.57	25.18	3.37	3.22	0.44	0.44	0.00	0.15	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	29.10	19.61	2.74	0.84	0.63	0.84	0.00	0.00	0.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	30.42	22.38	3.32	2.27	0.35	0.35	0.00	0.17	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	33.93	30.72	3.81	1.20	0.20	0.00	0.40	0.00	0.60	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	33.27	25.82	2.33	1.86	0.47	0.23	0.23	0.23	0.93	0.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	31.91	24.95	1.92	1.92	0.96	0.24	0.00	0.00	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	33.68	28.61	2.68	0.89	0.60	0.60	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	40.21	31.84	2.87	2.87	0.48	0.48	0.24	0.24	0.48	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	37.00	35.18	5.46	2.83	1.42	0.20	0.00	0.40	0.81	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	44.88	31.77	3.69	2.46	0.82	0.20	0.00	0.00	1.84	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	54.48	38.47	4.45	2.67	2.22	0.67	0.22	0.00	0.67	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	377.79	111.94	0.00	55.97	13.99	13.99	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	61.75	38.32	2.48	3.19	0.71	0.35	0.35	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	58.32	45.40	3.65	3.65	1.66	0.33	0.33	0.66	0.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	324.67	130.87	28.52	10.91	5.03	1.68	0.00	1.68	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	100.11	70.72	7.35	3.67	1.84	0.92	0.00	0.00	0.92	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	65.79	47.00	6.48	4.54	0.97	0.65	0.00	0.00	1.30	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	62.95	45.93	4.82	2.89	0.00	0.64	0.32	0.32	0.64	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	106.56	75.75	12.57	6.29	1.89	0.63	0.31	0.00	0.63	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	74.74	61.34	8.46	6.35	4.94	0.71	0.00	0.00	0.71	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	86.36	68.98	5.61	7.85	1.12	0.00	0.00	0.00	3.36	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	131.36	129.77	37.42	8.76	6.37	1.59	0.80	1.59	0.80	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	86.98	88.34	15.29	7.14	2.38	1.36	0.00	0.68	0.68	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	77.98	52.96	5.52	4.55	1.95	0.32	0.32	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	77.74	64.25	10.29	6.74	3.55	1.06	0.00	0.35	1.06	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	404.10	242.46	113.15	32.33	32.33	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	584.41	213.23	221.13	15.79	0.00	31.59	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	136.50	75.56	14.14	8.78	4.39	1.46	0.49	0.49	1.95	0.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	139.34	83.80	9.42	6.45	3.97	0.50	0.50	1.49	0.99	0.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	138.86	74.59	16.89	7.97	8.91	0.94	0.00	0.94	1.41	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	119.89	66.24	33.12	6.29	3.64	2.65	0.33	0.66	1.32	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	111.67	66.20	13.30	4.64	4.33	2.47	0.62	0.62	1.55	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	112.82	74.91	9.48	5.20	4.28	0.61	0.00	0.31	0.92	0.31
Adipocyte - breast, donor1	11376-118A8	0.79	25.18	30.09	9.82	0.48	2.85	0.16	0.48	0.32	0.16
Adipocyte - breast, donor2	11327-117E4	0.48	31.44	14.44	4.17	0.00	0.80	0.48	0.48	0.32	0.16
Adipocyte - omental, donor1	11473-119C6	2.67	52.54	80.66	11.32	1.40	5.34	1.65	0.89	0.64	0.76
Adipocyte - omental, donor2	11474-119C7	0.00	29.15	4.48	2.24	0.75	0.00	0.00	1.49	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	0.33	30.48	14.74	3.35	0.00	1.00	0.33	0.00	0.67	0.00
Adipocyte - perirenal, donor1	11476-119C9	0.64	47.85	17.23	3.83	0.64	1.28	0.00	0.00	0.00	0.00
Adipocyte - subcutaneous, donor1	11259-116F8	15.39	13.19	12.09	0.00	0.00	0.00	3.30	0.00	0.00	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	19.42	50.13	26.19	2.71	2.26	1.35	0.45	0.00	0.45	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	0.17	14.42	5.04	0.87	0.17	0.35	0.52	0.00	0.00	0.00
Adipocyte differentiation, day04, donor1	13019-139D4	18.58	29.14	43.42	7.43	2.93	1.96	1.37	0.20	0.00	1.37
Adipocyte differentiation, day04, donor2	13022-139D7	15.96	24.19	16.99	5.15	1.29	1.29	0.77	0.77	0.00	0.51
Adipocyte differentiation, day04, donor3	13025-139E1	14.22	37.63	39.86	7.81	1.39	2.51	0.56	0.56	0.00	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	60.54	29.98	38.80	12.93	2.35	4.11	0.00	0.00	0.00	0.59
Adipocyte differentiation, day08, donor1	13020-139D5	8.20	14.24	11.42	2.49	0.64	0.72	0.40	0.32	0.00	0.40
Adipocyte differentiation, day08, donor2	13023-139D8	79.72	20.33	27.76	6.46	3.23	0.97	0.00	0.00	0.32	0.65
Adipocyte differentiation, day08, donor3	13026-139E2	21.86	11.73	12.80	2.13	0.53	0.53	0.00	0.00	0.53	0.00
Adipocyte differentiation, day08, donor4	13029-139E5	7.79	15.58	10.02	6.68	1.11	0.56	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	2.91	14.14	6.24	2.91	0.00	0.42	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	31.65	18.59	17.58	6.28	0.75	1.26	1.76	1.00	0.25	0.00
Adipocyte differentiation, day12, donor3	13027-139E3	24.22	21.60	9.16	1.31	0.65	1.31	0.00	0.98	0.00	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	4.57	9.44	6.09	2.74	0.30	0.61	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	0.00	108.73	14.14	3.98	0.00	0.66	0.00	0.66	0.22	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	0.72	53.43	3.59	3.23	0.00	0.36	0.00	0.36	0.00	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	34.74	27.55	3.59	0.00	1.20	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	0.18	78.80	13.85	4.32	0.00	0.72	0.18	0.18	0.36	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	0.00	48.53	10.04	3.35	0.00	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	0.00	48.49	5.55	2.67	0.00	0.41	0.00	0.00	0.21	0.00
Anulus Pulposus Cell, donor1	11248-116E6	0.23	26.09	2.63	0.80	0.11	0.46	0.00	0.00	0.00	0.00
Anulus Pulposus Cell, donor2	11463-119B5	0.00	23.02	0.98	0.49	0.00	0.24	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	24.26	30.55	2.70	3.15	0.00	0.45	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	0.87	37.77	0.43	2.17	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	0.00	25.68	4.28	0.00	2.14	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	37.07	32.58	4.48	2.69	0.30	0.60	0.30	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	0.00	36.67	2.53	1.26	0.00	0.00	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	1.32	21.12	1.98	1.32	0.00	0.00	0.00	1.32	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	16.24	29.24	1.62	4.55	0.97	1.30	0.00	0.00	0.65	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	0.49	34.95	2.91	2.91	0.00	0.00	0.00	0.00	0.49	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	0.59	18.41	0.59	1.78	0.00	0.59	0.00	0.00	0.59	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	5.65	32.01	3.39	3.77	0.00	0.00	0.38	0.00	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	0.00	31.93	3.63	3.63	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	0.00	30.09	5.02	2.51	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	0.66	37.07	3.29	3.46	0.33	0.16	0.00	0.16	0.16	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	0.00	25.93	1.36	2.73	0.00	1.36	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	0.30	25.18	2.11	2.11	0.00	0.30	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	10.18	34.29	2.14	1.61	1.07	0.54	0.00	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	0.19	32.87	2.27	1.51	0.00	0.38	0.00	0.19	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	0.00	31.01	1.34	2.14	0.00	0.27	0.00	0.27	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	20.48	37.07	2.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	0.50	32.67	3.32	1.66	0.00	0.00	0.00	0.33	0.17	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	0.00	28.82	1.20	2.40	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	3.54	53.10	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	2.06	33.28	1.89	2.74	0.00	0.69	0.00	0.17	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	20.97	0.00	12.58	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	1.94	33.01	1.94	2.91	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	0.38	35.67	2.66	0.76	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	0.00	18.17	0.00	3.63	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	0.57	33.63	2.85	0.00	0.00	0.57	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	0.21	27.58	0.64	1.92	0.00	0.21	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	0.77	18.58	1.55	3.87	0.00	0.26	0.00	0.26	0.52	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	0.47	30.50	0.94	2.82	0.00	0.47	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	0.96	29.90	2.57	2.25	0.00	0.96	0.00	0.00	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	0.00	20.69	2.14	0.00	0.00	0.71	0.00	0.71	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	1.17	20.47	0.58	1.17	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	0.60	30.41	2.71	4.52	0.00	0.30	0.00	0.30	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	0.00	24.95	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	1.53	34.07	2.03	5.09	0.51	0.00	0.00	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	0.00	25.21	1.78	1.78	0.00	0.25	0.00	0.00	0.25	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	0.64	23.51	0.00	1.27	0.00	0.64	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	0.43	29.78	1.29	2.59	0.00	0.86	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	0.64	32.39	2.33	3.81	0.21	0.21	0.00	0.21	0.42	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	0.00	20.01	2.32	4.06	0.00	0.29	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	0.94	24.56	0.00	2.83	0.00	0.00	0.00	0.94	0.94	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	0.68	32.55	2.20	2.71	0.00	0.00	0.00	0.00	0.34	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	0.00	20.85	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	0.00	42.25	4.23	4.23	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	0.64	36.24	1.93	5.15	0.43	0.00	0.00	0.00	0.43	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	1.20	28.28	1.20	2.41	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	0.00	34.99	0.73	2.92	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	2.30	36.09	1.61	2.76	0.23	0.23	0.00	0.23	0.23	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	2.55	12.75	2.55	0.00	0.00	0.00	0.00	0.00	2.55	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	3.05	22.12	2.29	2.29	0.00	0.51	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	7.23	39.02	4.13	3.10	0.62	0.21	0.00	0.21	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.12	27.85	1.22	1.84	0.92	0.61	0.00	0.92	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	4.78	39.68	2.39	4.78	0.48	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	7.10	35.70	3.55	3.77	0.22	0.44	0.00	0.00	0.44	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	1.53	19.84	1.53	0.00	1.53	0.00	0.00	0.00	1.53	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	4.43	27.14	3.88	1.66	0.00	0.00	0.00	0.00	1.11	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	3.97	36.54	3.71	5.03	0.53	0.53	0.00	0.00	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	8.00	26.90	1.82	2.91	0.00	0.36	0.00	0.36	0.36	0.00
Astrocyte - cerebellum, donor1	11500-119F6	3.81	68.90	7.61	1.35	0.25	0.37	0.00	0.12	0.12	0.00
Astrocyte - cerebellum, donor2	11580-120F5	0.00	42.96	2.23	2.23	0.00	0.17	0.00	0.00	0.34	0.00
Astrocyte - cerebellum, donor3	11661-122F5	16.57	43.42	42.16	1.26	2.52	2.10	1.05	0.00	0.63	0.00
Astrocyte - cerebral cortex, donor1	11235-116D2	11.85	35.21	5.58	0.00	1.74	0.70	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	9.38	36.56	8.09	1.78	1.46	0.97	0.16	0.32	0.00	0.00
Astrocyte - cerebral cortex, donor3	11392-118C6	3.88	40.57	5.22	0.75	0.60	0.60	0.00	0.00	0.00	0.00
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	157.23	153.33	54.82	5.85	9.52	4.93	2.87	0.46	1.03	0.69
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	170.26	184.79	52.99	5.89	8.02	4.26	1.63	0.38	0.88	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	207.68	167.39	62.82	5.35	11.15	5.46	2.39	0.23	0.91	1.14
Basophils, donor1	12241-129G9	346.53	102.26	26.94	8.89	4.45	0.52	2.88	0.78	0.52	0.00
Basophils, donor2	12242-129H1	144.32	108.24	19.48	7.94	4.69	0.72	1.80	0.72	0.00	0.00
Basophils, donor3	12243-129H2	132.74	103.78	24.99	10.58	3.97	1.32	2.79	2.20	0.15	0.73
Bronchial Epithelial Cell, donor1	11511-119G8	0.00	44.63	4.96	2.37	0.00	0.22	0.00	0.65	0.00	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	0.00	29.26	1.37	0.91	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	0.00	21.52	0.00	7.17	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	0.63	33.89	0.00	2.51	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	0.00	52.40	1.25	1.46	0.00	0.00	0.00	0.42	0.00	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	0.69	102.25	17.96	5.99	0.23	0.46	0.00	0.69	0.46	0.00
Bronchial Epithelial Cell, donor7	11769-123I5	0.00	33.65	2.34	1.98	0.00	0.00	0.00	0.36	0.18	0.00
Burkitt's lymphoma cell line:DAUDI	10422-106C8	1.44	55.86	34.52	4.12	0.21	2.47	0.00	0.31	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	5.12	172.12	71.04	5.59	1.40	3.49	0.23	0.00	0.23	0.47
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	2.56	32.94	0.32	0.96	0.00	0.00	0.00	0.00	0.32	0.00
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	250.22	126.80	39.45	10.71	4.51	0.00	2.82	0.56	0.00	0.56
CD14+ Monocytes, donor2	11305-117B9	200.08	138.46	18.75	8.72	4.64	1.86	0.74	1.67	0.93	0.00
CD14+ Monocytes, donor3	11381-118B4	237.10	119.21	18.22	8.12	7.03	0.88	2.20	1.32	0.22	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	20.95	24.34	0.00	0.85	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	26.54	34.12	1.52	6.44	0.76	0.38	0.00	0.38	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	6.57	29.92	0.00	3.29	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	308.18	112.31	48.71	10.12	8.96	1.30	2.75	1.73	2.60	1.16
CD14+ monocytes - mock treated, donor2	11873-125C1	336.44	102.89	47.68	9.66	5.13	2.41	2.11	2.11	1.51	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	477.81	82.91	43.59	15.16	11.37	1.18	1.66	1.90	0.95	0.47
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	323.25	108.14	43.02	11.55	8.37	0.33	3.18	2.18	1.00	0.33
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	329.28	110.68	60.72	19.04	3.86	2.76	4.69	3.59	2.21	0.28
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	622.55	113.06	73.63	24.30	13.14	3.22	7.69	2.73	1.74	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	5257.64	166.43	21.54	6.85	32.50	0.39	0.59	0.98	10.18	3.13
CD14+ monocytes - treated with BCG, donor2	11870-125B7	3931.31	131.58	13.53	5.52	25.82	0.18	0.71	1.07	6.94	3.03
CD14+ monocytes - treated with BCG, donor3	11880-125C8	7415.53	143.64	28.94	8.49	49.62	1.31	2.18	2.39	5.66	2.83
CD14+ monocytes - treated with Candida, donor1	11868-125B5	410.42	132.28	50.57	13.58	6.79	1.87	4.92	4.68	2.34	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	417.14	134.12	57.03	22.18	10.03	0.53	8.45	3.17	1.06	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	722.19	103.17	69.89	29.95	15.53	0.00	8.87	5.55	1.11	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	352.98	120.34	48.64	11.90	7.14	3.27	3.57	2.38	2.53	0.74
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	355.99	108.95	66.05	17.96	7.58	2.99	5.19	3.19	3.39	1.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	609.82	89.94	68.50	20.40	13.95	3.75	5.20	3.33	1.25	0.42
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	583.40	171.59	80.53	22.19	8.47	4.12	7.78	1.83	2.52	1.14
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	687.21	156.31	92.74	27.60	11.54	5.20	9.95	2.71	1.81	0.45
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	928.79	124.39	80.31	27.93	20.08	3.93	17.46	2.18	2.18	1.31
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	3238.64	148.75	13.45	3.23	29.32	0.00	0.27	1.34	6.46	2.15
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	3631.91	139.57	17.45	4.71	31.58	0.87	1.57	0.35	8.90	3.14
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	4124.04	122.04	23.15	6.31	51.76	1.26	0.42	0.00	5.47	2.52
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	767.36	185.73	75.87	37.84	13.23	4.78	5.70	5.33	2.76	1.47
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	730.60	187.41	65.52	29.24	8.81	3.17	4.93	3.87	2.11	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	1101.64	141.71	74.58	34.66	17.11	2.63	4.83	4.83	2.63	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	2950.41	129.39	16.39	5.75	17.96	1.39	0.70	0.52	8.54	2.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	3010.21	123.03	11.89	3.35	24.53	0.00	0.74	0.37	7.06	1.12
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	5202.28	154.76	35.35	6.47	44.62	0.22	0.86	1.08	5.17	3.23
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	1152.71	180.99	74.53	32.76	14.33	4.91	3.69	2.87	3.28	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	1237.81	188.22	94.11	43.11	13.91	3.48	8.11	4.87	1.16	2.32
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	1669.65	147.31	88.39	41.99	18.10	3.25	6.03	5.34	1.16	1.62
CD14+CD16+ Monocytes, donor1	11789-124B7	1039.69	119.01	82.17	21.58	15.04	3.05	3.49	2.62	1.74	0.22
CD14+CD16+ Monocytes, donor2	11801-124D1	1008.52	104.87	86.39	24.02	16.86	1.39	3.23	2.31	3.00	0.92
CD14+CD16+ Monocytes, donor3	11912-125G4	940.98	118.71	50.25	17.33	9.10	1.30	1.30	2.38	0.65	0.22
CD14+CD16- Monocytes, donor1	11788-124B6	180.48	144.51	35.82	28.19	3.89	2.34	0.93	2.80	0.78	0.00
CD14+CD16- Monocytes, donor2	11799-124C8	234.72	102.69	39.82	27.59	4.02	0.70	1.57	2.97	0.17	0.17
CD14+CD16- Monocytes, donor3	11910-125G2	309.26	179.27	38.13	30.55	2.45	1.78	0.89	2.23	0.45	0.89
CD14-CD16+ Monocytes, donor1	11790-124B8	547.86	111.51	78.34	10.97	12.76	2.30	3.32	3.06	0.77	1.53
CD14-CD16+ Monocytes, donor2	11800-124C9	876.50	110.44	99.46	20.64	18.66	1.98	3.73	3.73	2.85	0.66
CD14-CD16+ Monocytes, donor3	11911-125G3	1171.48	137.28	92.64	14.32	13.69	1.89	4.63	2.32	1.89	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	18.29	30.48	0.00	0.00	2.03	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	13.56	25.09	1.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	13.46	27.96	1.04	0.00	1.04	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	52.24	60.23	12.26	6.40	0.00	0.00	0.00	0.53	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	21.98	73.44	6.43	3.75	3.22	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	19.65	32.29	0.00	0.00	0.70	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	21.96	37.65	1.57	0.78	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	17.14	27.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor1	11544-120B5	8.22	52.60	2.47	5.75	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	29.02	31.92	2.18	1.45	0.73	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	15.14	45.94	2.02	4.54	0.00	0.00	0.00	0.50	0.00	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	1.62	77.98	4.44	7.68	0.40	0.00	0.40	0.00	0.00	0.40
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	2.00	42.35	5.59	6.39	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor1	11545-120B6	0.00	12.05	1.00	1.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	46.63	62.92	7.87	1.12	2.25	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	1.50	48.10	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	2.03	51.64	1.35	1.58	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor1	11225-116C1	1.43	33.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor2	11306-117C1	1.84	18.98	0.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+ T Cells, donor3	11382-118B5	3.05	26.23	0.00	0.00	0.30	0.00	0.00	0.00	0.30	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	5.36	46.45	0.26	1.79	1.79	0.00	0.26	0.26	0.26	0.77
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	10.56	55.70	2.92	2.70	2.25	0.00	0.00	0.00	0.45	1.35
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	6.90	52.03	1.72	0.29	1.15	0.00	0.29	0.00	0.00	1.15
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	0.00	20.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	0.00	26.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	0.00	16.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	6.94	38.15	0.87	2.46	1.16	0.00	0.00	0.14	0.29	0.14
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	13.22	36.94	3.05	3.73	2.20	0.00	0.17	0.00	0.68	1.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	23.21	39.66	1.29	2.10	4.19	0.00	0.00	0.00	0.32	1.45
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	0.90	21.97	0.45	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	1.75	24.46	0.35	0.00	0.00	0.00	0.35	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	1.32	32.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	3.79	45.54	0.42	0.84	0.42	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	6.03	36.57	1.87	1.66	1.25	0.00	0.00	0.00	0.00	0.42
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	4.68	28.73	0.00	0.33	0.00	0.00	0.00	0.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	0.00	31.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	0.00	31.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	0.00	37.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	4.64	48.40	0.74	0.74	1.11	0.19	0.00	0.00	0.19	0.37
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	5.20	44.19	1.73	1.52	1.30	0.00	0.00	0.43	0.43	0.43
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	2.73	35.94	0.21	0.21	0.42	0.00	0.00	0.00	0.42	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	0.00	20.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	0.00	23.40	0.00	0.43	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	0.44	41.40	0.00	0.00	0.44	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	5.94	32.17	0.00	0.00	0.49	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	0.00	30.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	1.40	26.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	30.74	52.62	2.77	2.22	0.83	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	15.71	68.46	1.72	1.23	0.00	0.00	0.00	0.25	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	16.94	43.12	1.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	22.20	39.75	2.86	0.36	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	15.23	44.32	1.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	1.31	41.91	0.65	1.31	0.65	0.00	0.00	0.00	0.00	0.33
CD8+ T Cells, donor2	11307-117C2	0.00	25.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	0.25	32.32	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	389.05	162.41	12.39	0.46	6.65	0.23	0.00	0.00	2.06	0.23
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	380.79	144.74	13.66	0.48	6.95	0.48	0.48	0.00	2.88	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	430.09	151.57	15.05	0.55	10.40	0.27	0.55	0.00	2.46	0.55
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	564.70	171.72	16.21	0.60	13.81	1.20	0.00	0.00	1.20	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	399.57	142.79	12.48	0.96	7.20	0.96	0.48	0.00	1.20	0.00
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	441.13	138.93	15.23	0.91	10.69	0.68	0.00	0.45	0.68	0.68
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	292.46	187.30	6.30	1.74	3.04	0.65	0.22	0.00	0.65	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	319.27	165.56	10.26	1.58	4.74	0.79	0.26	0.00	1.05	0.26
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	276.73	166.04	7.97	1.17	2.81	1.17	0.23	0.23	1.64	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	513.80	225.80	12.38	0.91	9.36	0.00	0.30	0.91	1.21	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	490.95	194.35	14.23	1.16	8.72	1.16	0.87	0.00	1.45	0.00
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	516.08	196.36	11.72	0.53	6.93	0.53	1.60	0.00	1.87	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	1464.28	179.04	31.52	2.19	9.19	0.00	1.31	0.00	2.19	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	1500.18	188.55	22.77	0.91	11.39	1.82	1.82	0.00	3.19	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	1220.99	138.73	14.92	0.00	12.68	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	496.65	153.79	16.57	1.08	11.89	1.08	0.36	0.00	1.44	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	429.57	154.22	14.10	0.29	14.96	1.15	0.29	0.29	0.86	0.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	393.85	147.07	14.61	0.94	12.96	0.24	0.71	0.24	0.24	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	370.78	182.54	11.09	0.95	4.12	0.63	0.32	0.00	1.90	0.32
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	326.63	176.23	8.30	0.92	3.69	0.00	0.31	0.00	1.54	0.00
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	321.22	184.66	8.01	2.24	6.41	0.32	0.00	0.00	0.96	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	658.22	198.88	14.15	0.38	9.18	1.53	0.38	0.00	0.76	0.76
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	585.64	209.66	14.19	1.18	6.31	0.39	0.39	0.39	1.58	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	624.80	183.81	12.86	0.76	7.56	0.76	0.76	0.00	1.51	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	1853.22	292.28	103.58	7.23	19.27	9.64	3.21	1.61	4.82	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	1717.80	276.97	100.02	14.69	24.48	4.90	2.80	0.00	4.20	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	2312.04	306.54	96.17	8.01	17.03	9.02	6.01	4.01	2.00	0.00
Cardiac Myocyte, donor1	11525-119I4	9.14	7.31	1.83	1.83	0.00	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	34.59	37.06	43.97	5.43	4.45	2.47	0.49	0.49	0.49	0.00
Cardiac Myocyte, donor3	11686-122I3	3.79	49.04	171.42	7.58	0.84	5.37	4.00	1.26	0.32	0.21
Chondrocyte - de diff, donor1	11261-116G1	18.03	82.16	66.56	11.44	1.39	3.47	1.04	2.08	0.00	0.00
Chondrocyte - de diff, donor2	11338-117F6	29.50	41.22	56.50	7.46	2.49	4.62	4.98	0.36	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	15.82	32.43	54.39	8.87	1.48	3.53	7.74	1.25	1.14	0.57
Chondrocyte - re diff, donor2	11339-117F7	27.75	94.00	51.03	31.33	0.00	3.58	0.90	1.79	0.00	0.00
Chondrocyte - re diff, donor3	11411-118E7	222.02	28.31	21.84	10.11	3.24	1.21	0.00	0.40	0.40	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	5.51	56.58	16.30	1.84	1.03	1.38	0.00	0.11	0.11	0.23
Ciliary Epithelial Cells, donor2	11323-117D9	0.43	44.04	12.40	1.50	0.43	0.43	0.00	0.43	0.43	0.00
Ciliary Epithelial Cells, donor3	11399-118D4	2.39	54.16	11.95	1.59	0.27	1.06	0.18	0.09	0.62	0.09
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	145.62	97.94	9.08	3.12	1.83	0.37	0.73	0.37	0.37	0.37
Corneal Epithelial Cells, donor1	11526-119I5	0.44	94.42	14.71	7.90	0.00	0.66	0.00	1.10	0.00	0.00
Corneal Epithelial Cells, donor2	11606-120I4	0.00	53.47	0.00	0.00	0.00	0.00	0.00	0.00	1.14	0.00
Corneal Epithelial Cells, donor3	11687-122I4	0.26	58.80	6.90	1.28	0.00	0.26	0.00	0.26	0.51	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	48.37	66.20	10.57	14.03	1.49	0.66	0.66	1.16	0.17	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	34.70	66.55	7.25	11.35	2.21	0.63	1.89	0.32	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	34.51	55.21	10.35	3.45	0.00	0.00	0.00	0.00	3.45	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	44.71	69.98	26.89	15.33	3.67	1.62	2.16	1.84	0.54	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	14.69	87.12	2.73	0.68	0.34	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	24.81	65.29	0.65	1.31	1.96	0.00	0.65	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	3.87	63.40	0.48	0.97	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	4.67	54.87	40.86	16.68	0.67	3.50	1.17	2.67	0.00	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	3.52	44.01	16.43	6.45	0.00	0.59	0.59	0.59	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	6.22	44.96	35.92	8.48	1.98	2.26	1.70	0.85	0.00	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	7.08	36.96	19.66	6.29	1.18	1.18	1.97	0.79	0.79	0.00
Endothelial Cells - Artery, donor1	11264-116G4	11.34	42.47	46.54	9.02	0.87	2.33	4.36	0.87	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	8.94	51.29	50.82	13.65	1.88	3.06	1.41	1.18	0.71	0.24
Endothelial Cells - Artery, donor3	11413-118E9	6.31	43.83	30.50	10.17	1.05	1.93	1.58	1.05	0.00	0.00
Endothelial Cells - Lymphatic, donor1	11236-116D3	51.87	41.89	162.69	17.73	5.32	11.08	15.07	3.32	0.00	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	100.41	46.55	199.29	17.34	8.22	11.56	35.60	2.43	0.61	1.83
Endothelial Cells - Lymphatic, donor3	11393-118C7	117.84	51.59	294.59	33.26	7.61	18.04	37.78	3.66	0.85	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	116.77	73.69	109.35	44.27	7.73	5.94	3.27	4.46	0.89	0.30
Endothelial Cells - Microvascular, donor2	11342-117G1	73.93	39.05	114.55	29.16	3.12	6.25	8.33	4.69	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	66.64	23.68	80.39	28.22	7.23	6.38	7.80	5.39	1.13	0.43
Endothelial Cells - Thoracic, donor1	11266-116G6	10.80	59.22	35.21	21.21	2.00	2.80	1.20	2.00	0.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	5.77	38.26	33.54	10.48	1.57	1.57	0.52	1.57	0.00	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	27.09	78.77	144.13	25.47	3.60	7.83	5.47	4.47	0.37	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	12.82	44.10	40.41	8.69	1.30	3.26	1.09	2.39	0.22	0.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	13.19	45.19	48.73	10.75	1.34	3.42	1.34	0.73	0.12	0.00
Endothelial Cells - Vein, donor1	11267-116G7	1.14	19.34	13.65	2.28	0.00	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Vein, donor2	11344-117G3	3.49	52.39	13.97	4.89	0.00	2.79	0.70	0.00	0.00	0.00
Endothelial Cells - Vein, donor3	11416-118F3	2.83	39.25	11.93	4.87	0.94	1.73	0.31	0.16	0.00	0.00
Eosinophils, donor1	12244-129H3	30.49	60.99	15.25	15.25	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	315.20	191.43	29.70	8.25	1.65	1.65	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	388.78	206.88	17.83	14.27	0.00	3.57	3.57	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	0.49	47.64	4.89	3.42	0.00	0.00	0.24	0.49	0.49	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	0.00	54.08	2.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	0.00	16.27	32.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	16.42	37.36	94.42	8.62	2.46	4.93	4.52	0.41	0.82	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	7.66	18.07	20.15	1.97	1.09	0.77	0.99	0.11	0.77	0.22
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	8.23	52.65	94.90	4.01	2.28	2.82	3.47	0.22	1.73	0.87
Fibroblast - Aortic Adventitial, donor1	11245-116E3	5.22	53.85	111.82	8.85	2.06	5.94	2.18	0.73	1.09	0.12
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	20.47	66.19	101.26	5.32	2.59	4.50	5.46	0.55	0.00	0.96
Fibroblast - Aortic Adventitial, donor2	11326-117E3	12.76	39.55	92.29	5.27	3.27	3.16	2.74	0.21	1.37	0.63
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	20.82	77.99	140.70	4.22	2.37	4.22	3.16	1.05	1.58	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	8.30	50.16	63.78	3.99	1.99	3.32	1.99	0.33	0.66	0.33
Fibroblast - Cardiac, donor1	11268-116G8	4.08	35.84	48.08	5.90	0.00	1.81	1.81	0.00	0.00	0.45
Fibroblast - Cardiac, donor2	11345-117G4	3.03	52.30	53.81	11.37	0.00	1.52	0.00	0.76	0.00	0.00
Fibroblast - Cardiac, donor3	11417-118F4	27.60	35.96	48.89	3.00	2.37	2.37	2.52	0.95	0.79	0.47
Fibroblast - Cardiac, donor4	11452-119A3	4.24	26.37	18.79	3.64	0.91	1.82	0.30	0.61	0.30	0.30
Fibroblast - Cardiac, donor5	11456-119A7	4.95	62.82	60.41	5.33	0.51	3.43	1.27	1.14	0.38	0.00
Fibroblast - Cardiac, donor6	11460-119B2	1.52	32.44	18.04	5.31	0.45	0.91	0.15	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor1	11492-119E7	2.68	58.15	21.04	3.75	0.67	0.54	0.27	0.27	0.13	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	0.86	17.26	7.33	1.29	0.00	0.00	0.43	0.00	0.00	0.00
Fibroblast - Choroid Plexus, donor3	11653-122E6	0.00	92.28	32.23	4.39	0.00	1.46	0.00	1.46	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	13.61	252.55	249.09	6.23	0.46	12.45	2.77	0.00	0.00	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	2.04	24.42	51.22	4.41	0.34	1.02	0.68	0.00	0.34	0.34
Fibroblast - Dermal, donor1	11269-116G9	0.47	49.54	3.29	3.29	0.23	0.00	0.00	0.00	0.23	0.00
Fibroblast - Dermal, donor2	11346-117G5	0.00	88.20	9.43	7.08	0.00	0.00	0.00	0.47	0.00	0.00
Fibroblast - Dermal, donor3	11418-118F5	0.36	49.81	10.52	6.17	0.12	1.21	0.12	0.48	0.36	0.00
Fibroblast - Dermal, donor4	11450-119A1	0.23	63.64	9.83	2.83	0.00	0.45	0.00	0.11	0.79	0.00
Fibroblast - Dermal, donor5	11454-119A5	0.35	76.24	14.65	1.74	0.17	1.40	0.00	0.35	0.00	0.00
Fibroblast - Dermal, donor6	11458-119A9	0.49	72.93	4.71	2.92	0.16	0.00	0.00	0.16	0.32	0.00
Fibroblast - Gingival, donor1	11237-116D4	0.00	49.77	15.20	3.54	0.00	0.62	0.00	0.83	0.00	0.00
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	2.88	67.33	47.95	8.65	0.26	2.36	0.26	1.31	1.05	0.26
Fibroblast - Gingival, donor2	11318-117D4	0.26	46.65	10.02	1.58	0.00	1.05	0.26	0.13	0.40	0.00
Fibroblast - Gingival, donor3	11394-118C8	1.55	50.28	49.79	5.51	0.29	4.25	0.77	0.19	0.29	0.10
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	42.59	65.45	25.97	12.47	1.04	4.16	0.00	0.00	3.12	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	35.06	47.40	46.52	4.58	2.64	1.41	0.88	0.35	1.41	0.00
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	1.09	44.90	2.96	2.34	0.00	0.16	0.00	0.16	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	0.68	45.98	1.49	2.16	0.14	0.27	0.00	0.00	0.14	0.00
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	0.35	31.76	1.41	1.06	0.35	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	0.58	36.56	4.68	2.19	0.00	0.58	0.00	0.15	0.00	0.00
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	0.14	34.63	2.73	1.50	0.00	0.55	0.00	0.14	0.00	0.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	0.11	51.12	9.54	3.40	0.11	0.66	0.33	0.11	0.44	0.00
Fibroblast - Gingival, donor9 (control)	11927-125I1	1.03	50.04	32.14	11.15	0.29	1.03	0.59	0.44	0.15	0.00
Fibroblast - Lung, donor1	11270-116H1	5.44	38.06	19.03	4.08	0.00	1.36	0.00	1.36	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	2.98	53.72	17.91	4.48	1.49	0.00	0.00	0.00	0.00	0.00
Fibroblast - Lung, donor3	11419-118F6	0.84	44.95	8.02	5.06	0.42	0.00	0.21	0.42	0.00	0.00
Fibroblast - Lymphatic, donor1	11506-119G3	20.83	224.08	89.97	27.49	1.67	0.83	0.00	2.50	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	15.38	65.74	48.95	9.79	0.00	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	14.55	42.26	34.14	1.96	2.80	0.84	0.28	0.00	0.28	1.40
Fibroblast - Mammary, donor1	11540-120B1	1.62	193.24	69.42	21.92	0.41	5.68	0.41	2.44	0.00	0.00
Fibroblast - Mammary, donor2	11620-122A9	0.00	51.92	27.96	7.99	0.00	3.99	0.00	0.00	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	11.91	89.34	71.48	5.96	0.00	0.00	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	0.19	57.03	12.22	3.49	0.00	0.39	0.19	0.58	0.39	0.00
Fibroblast - Periodontal Ligament, donor2	11319-117D5	0.30	62.64	11.68	3.64	0.00	1.67	0.00	0.30	0.76	0.00
Fibroblast - Periodontal Ligament, donor3	11395-118C9	0.31	60.59	9.18	3.06	0.00	0.31	0.31	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	0.76	54.95	14.88	2.67	0.00	1.14	0.38	0.00	0.76	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	1.08	55.35	35.10	4.86	0.00	1.08	0.81	0.54	0.00	0.00
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	26.33	44.65	37.92	5.91	0.93	2.90	1.16	0.81	0.23	0.12
Fibroblast - Pulmonary Artery, donor1	11250-116E8	0.77	37.69	26.86	9.06	0.44	0.77	0.44	0.55	0.22	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	19.71	144.27	59.33	11.18	1.83	3.05	1.42	0.41	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	2.00	78.85	22.72	2.67	0.00	0.00	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	2.37	35.19	15.42	5.93	0.00	1.19	0.00	0.00	0.40	0.79
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	3.77	82.75	56.16	5.16	0.00	2.58	0.99	0.79	0.60	0.00
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	2.66	53.29	72.29	8.88	0.36	3.02	0.89	0.71	0.18	0.71
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	2.76	60.31	85.53	12.81	0.59	2.17	1.38	0.39	0.00	0.39
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	1.20	69.50	36.10	9.03	0.60	1.20	0.90	1.81	0.60	0.30
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	2.27	71.57	55.27	18.03	0.65	3.67	0.65	1.62	0.65	0.11
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	20.50	101.74	144.00	11.64	3.54	4.05	4.05	1.77	1.27	0.51
Fibroblast - skin normal, donor1	11553-120C5	7.55	73.18	80.40	12.96	2.30	2.95	2.63	1.80	0.49	0.16
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	3.61	82.41	71.78	7.62	1.20	5.01	3.01	1.00	0.20	0.20
Fibroblast - skin normal, donor2	11561-120D4	6.33	114.33	70.12	13.96	1.21	3.32	0.30	1.61	0.90	0.00
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	4.23	113.34	95.51	12.39	0.30	3.63	1.21	1.81	0.91	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	2.49	51.78	80.53	13.01	0.91	3.73	0.66	0.66	0.41	0.58
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	26.33	59.66	89.75	8.38	5.81	1.88	0.68	0.17	0.85	0.51
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	3.28	62.40	42.37	7.88	0.00	1.97	1.31	0.66	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	1.28	67.75	26.10	7.14	0.21	1.17	0.43	0.64	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	0.84	65.11	15.18	4.72	0.00	0.34	0.17	0.17	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	9.41	73.55	107.74	13.96	2.04	3.29	5.18	0.63	0.47	0.63
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	22.16	398.88	531.84	88.64	0.00	22.16	44.32	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	9.59	17.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	1.04	39.70	3.29	1.21	0.17	0.17	0.00	0.17	0.17	0.00
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	1.82	70.53	2.08	1.30	0.00	0.00	0.00	0.00	0.00	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	0.51	60.56	5.37	2.30	0.00	0.00	0.00	0.00	0.51	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	1.53	48.23	9.95	0.77	0.00	0.00	0.00	0.00	0.77	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	0.64	57.43	12.76	0.00	0.00	3.19	0.64	0.00	0.64	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	0.86	83.30	31.66	2.57	0.00	2.85	0.57	0.00	0.86	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	0.00	36.95	3.03	0.28	0.00	0.00	0.00	0.00	0.28	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	2.05	46.35	5.48	0.46	0.23	0.46	0.00	0.00	1.14	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	0.99	55.28	17.44	1.59	0.00	0.59	0.59	0.20	0.59	0.20
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	0.00	37.27	3.97	0.26	0.00	0.00	0.26	0.00	0.79	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	2.61	48.60	9.46	0.33	0.33	0.33	0.65	0.33	1.96	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	0.44	59.70	16.36	0.88	0.00	2.21	0.00	0.00	0.44	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	1.41	51.87	18.23	1.13	0.14	1.98	0.00	0.28	0.57	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	4.56	52.09	18.96	0.37	0.62	2.09	0.86	0.12	1.11	0.00
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	2.42	52.38	18.27	3.22	0.54	1.34	0.27	0.00	0.27	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	42.25	65.17	36.80	1.98	0.25	4.96	0.50	0.37	0.50	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	11.49	69.07	52.19	2.08	0.97	6.78	1.38	0.55	1.80	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	13.42	69.94	66.28	0.61	0.61	5.08	1.22	0.41	0.41	0.00
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	12.78	47.46	45.64	1.60	0.68	2.51	0.68	0.23	0.23	0.23
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	4.98	52.44	61.54	1.99	1.74	6.73	1.25	0.25	1.00	0.12
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	6.99	59.89	72.35	3.28	0.44	6.12	3.50	0.44	0.87	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	4.43	37.53	19.50	1.18	0.89	1.18	0.89	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	6.68	45.30	30.68	0.79	0.64	3.18	0.48	0.16	0.95	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	4.69	47.36	48.26	1.12	0.45	2.68	1.12	0.22	0.45	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	2.62	33.07	18.15	0.40	1.21	0.81	0.20	0.00	0.20	0.40
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	3.56	45.97	15.44	0.51	0.68	1.02	0.34	0.00	0.51	0.00
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	5.94	61.01	56.31	1.68	0.71	2.66	1.24	0.27	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	2.91	46.30	14.67	0.52	0.42	0.94	0.31	0.00	0.31	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	4.10	49.70	11.61	0.51	0.51	0.68	0.00	0.00	0.34	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	1.44	33.75	9.07	0.33	0.89	0.77	0.33	0.00	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	3.66	52.00	29.70	1.25	0.67	1.50	0.92	0.17	0.17	0.08
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	3.68	47.37	26.34	1.02	1.23	0.61	0.41	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	2.06	31.98	8.87	0.21	0.62	0.21	0.21	0.00	0.21	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	2.19	31.59	7.26	0.12	0.46	0.23	0.12	0.00	0.23	0.00
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	4.00	36.19	9.67	0.00	0.67	0.17	0.67	0.00	0.17	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	4.19	26.89	3.75	0.22	0.66	0.44	0.22	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	4.92	32.47	8.49	0.37	0.74	1.11	0.12	0.00	0.61	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	4.21	39.06	9.73	0.65	0.65	0.65	0.32	0.00	0.16	0.32
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	5.77	28.86	8.66	0.64	2.25	0.64	0.00	0.00	0.32	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	3.22	30.23	4.45	0.09	0.95	0.47	0.28	0.09	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	9.81	37.96	8.38	0.32	1.58	0.32	0.32	0.16	0.47	0.16
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	5.17	35.88	9.43	0.30	1.82	0.61	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	3.97	37.95	6.48	0.63	0.52	0.31	0.10	0.00	0.31	0.10
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	9.88	34.69	10.54	0.66	1.98	0.22	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	6.45	34.23	5.61	0.28	0.56	0.84	0.28	0.00	0.28	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	4.44	33.61	2.96	0.65	0.93	0.46	0.00	0.00	0.09	0.00
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	15.24	53.75	8.29	1.34	1.60	0.27	0.00	0.00	1.07	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	7.04	40.55	6.58	0.46	0.77	0.31	0.46	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	4.53	41.84	4.02	0.52	1.04	0.39	0.13	0.00	0.39	0.13
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	20.06	47.71	12.47	0.54	4.07	0.27	0.27	0.00	0.81	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	1.84	37.98	8.30	1.11	0.55	0.55	0.37	0.00	0.74	0.18
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	3.51	35.75	5.26	1.10	0.22	0.44	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	16.86	56.53	9.92	0.99	4.96	0.99	0.99	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	3.03	32.85	11.08	1.32	0.66	0.40	0.26	0.13	0.53	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	1.21	33.69	10.49	1.41	0.61	0.20	0.61	0.00	0.20	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	14.49	61.00	27.96	3.05	3.81	0.76	0.51	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	0.80	92.56	27.07	5.97	0.20	1.99	0.00	0.40	1.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	2.93	52.85	18.49	2.00	0.00	2.16	0.15	0.00	0.62	0.00
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	1.02	66.90	28.03	2.66	0.20	4.91	0.00	0.61	1.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	0.31	47.57	14.71	0.94	0.63	0.31	0.00	0.31	0.31	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	0.57	41.82	13.00	0.57	0.00	0.85	0.28	0.00	0.28	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	0.46	53.50	11.53	0.00	0.00	0.46	0.00	0.00	0.46	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	2.47	61.87	17.32	0.00	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	1.55	61.50	20.50	0.77	0.00	0.39	1.16	0.39	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	3.21	43.32	9.63	4.81	0.00	0.00	0.00	0.00	1.60	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	1.74	52.16	33.04	0.00	0.00	0.00	0.00	0.00	1.74	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	1.95	54.68	20.18	0.98	0.33	0.98	0.00	0.33	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	2.06	45.30	23.88	0.82	0.41	1.65	0.82	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	0.00	33.32	13.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	1.40	37.75	11.75	0.00	0.00	0.28	0.28	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	1.31	55.56	19.61	0.98	0.98	0.33	0.98	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	0.00	34.39	8.39	0.84	0.84	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	1.27	36.26	7.63	0.00	0.00	0.64	0.00	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	0.34	45.18	12.57	0.34	0.68	0.68	0.00	0.00	0.68	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	0.00	37.59	0.00	2.09	0.00	2.09	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	0.00	40.09	12.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	0.30	34.93	6.81	0.59	0.00	0.00	0.30	0.00	0.30	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	0.00	22.02	1.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	0.83	43.49	4.14	0.41	0.41	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	0.69	37.74	4.60	0.23	0.23	0.23	0.23	0.00	0.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	47.42	10.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	0.00	29.60	1.92	0.00	0.00	0.00	0.00	0.00	0.77	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	0.98	26.40	2.93	0.00	0.33	0.33	0.00	0.00	0.98	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	0.67	16.72	4.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	0.00	24.27	3.08	0.00	0.00	0.00	0.00	0.00	0.39	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	0.34	34.92	6.50	0.68	0.68	0.00	0.00	0.34	1.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	29.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	0.00	20.29	2.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	0.00	27.16	3.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	0.00	22.89	5.60	0.00	0.51	0.00	0.00	0.00	0.51	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	0.00	34.30	2.39	0.00	0.00	0.00	0.00	0.00	0.40	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	0.49	19.73	1.97	0.00	0.00	0.00	0.00	0.00	0.49	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	0.00	34.23	1.18	0.00	0.00	1.18	0.00	0.00	1.18	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	0.00	21.59	3.50	0.58	0.00	0.00	0.58	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	0.00	24.14	3.07	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	0.85	12.72	0.85	0.00	0.00	0.00	0.00	0.00	0.85	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	0.00	23.28	1.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	0.00	30.57	3.88	0.49	0.00	0.00	0.49	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	21.68	46.79	9.13	2.28	3.42	0.00	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.99	27.44	4.16	0.42	0.00	0.00	0.00	0.00	0.83	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	2.25	46.10	2.25	2.25	1.12	0.00	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	0.00	14.91	2.22	1.59	0.32	0.32	0.00	0.00	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	0.42	18.38	7.52	3.34	0.84	0.42	0.84	0.00	0.00	0.00
Hep-2 cells mock treated, biol_rep1	11898-125E8	79.26	71.48	31.10	1.62	0.35	0.58	7.89	0.12	0.46	0.12
Hep-2 cells mock treated, biol_rep2	11899-125E9	100.10	78.32	27.35	1.52	0.84	0.34	5.23	0.00	1.18	0.17
Hep-2 cells mock treated, biol_rep3	11900-125F1	60.52	80.99	23.43	0.68	0.00	0.23	5.92	0.00	0.00	0.00
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	86.79	72.91	28.97	2.08	1.09	0.22	8.53	0.11	0.87	0.44
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	94.13	78.23	27.29	0.43	0.64	0.21	9.24	0.21	0.64	0.21
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	66.52	72.33	29.71	1.08	0.86	0.43	6.89	0.22	0.65	0.43
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	77.84	66.13	24.66	0.62	0.62	0.12	6.10	0.12	0.50	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	87.15	62.62	25.05	1.03	0.86	0.86	5.83	0.00	0.34	0.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	63.11	53.82	17.94	0.64	0.00	0.96	6.09	0.00	0.64	0.00
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	80.59	83.94	96.81	12.31	3.36	2.24	4.48	3.36	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	3.03	53.23	44.58	6.92	0.00	1.30	0.00	0.43	0.00	0.43
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	31.73	42.30	116.33	18.51	2.64	2.64	5.29	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	1.41	61.02	22.22	4.94	0.00	0.35	0.00	0.35	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	0.00	33.42	13.08	4.36	0.73	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	14.16	66.61	53.50	2.80	0.52	2.80	1.57	0.70	1.05	0.35
Hepatocyte, donor1	11523-119I2	1.21	14.53	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	17.24	24.78	3.23	7.54	1.08	0.00	0.00	1.08	0.00	0.00
Hepatocyte, donor3	11684-122I1	15.34	28.22	8.59	0.61	1.23	0.00	0.00	0.61	0.61	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	0.00	48.95	0.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Intestinal epithelial cells (polarized), donor1	11246-116E4	1.22	43.52	4.19	1.40	0.00	0.00	0.17	0.17	0.17	0.00
Iris Pigment Epithelial Cells, donor1	11530-119I9	1.37	48.98	35.81	2.20	0.69	1.92	0.69	0.00	0.27	0.14
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	0.00	95.52	9.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	0.00	86.78	53.40	0.00	0.00	0.00	0.00	0.00	0.00	20.03
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	27.08	27.08	0.00	0.00	0.00	0.00	0.00	0.00	27.08
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	2.77	73.37	20.77	0.00	0.00	1.38	2.77	0.00	0.00	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	5.01	115.12	75.08	2.50	2.50	2.50	2.50	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	71.21	11.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	71.76	33.32	0.00	0.00	0.00	2.56	0.00	5.13	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	9.14	118.84	59.42	4.57	0.00	0.00	0.00	0.00	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	0.00	108.83	24.36	0.00	0.00	0.00	0.00	0.00	0.00	1.62
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	0.00	63.36	15.01	1.67	0.00	0.00	1.67	0.00	1.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	10.89	87.13	61.72	3.63	0.00	0.00	0.00	3.63	7.26	7.26
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	0.00	75.44	27.79	0.00	0.00	0.00	0.00	0.00	0.00	3.97
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	0.00	46.56	13.30	1.11	0.00	0.00	2.22	0.00	0.00	1.11
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	104.77	52.38	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	0.63	60.47	18.27	0.63	0.00	0.63	0.00	0.63	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	0.00	71.14	27.84	1.55	0.00	0.00	1.55	0.00	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	0.00	73.17	29.27	14.63	0.00	0.00	0.00	0.00	0.00	14.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	1.29	80.75	17.44	2.58	0.00	1.94	0.00	0.00	0.65	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	3.22	74.06	20.93	0.00	0.00	3.22	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	0.00	107.53	59.74	23.90	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	0.81	76.60	22.82	3.26	0.00	0.00	0.00	0.00	1.63	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	89.42	31.91	0.42	0.84	0.42	0.00	0.00	0.00	1.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	57.49	71.86	14.37	14.37	0.00	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	3.21	63.49	20.90	0.80	0.00	0.80	0.80	0.80	0.00	0.80
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	0.00	62.78	17.54	0.92	0.00	0.00	0.00	0.00	0.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	90.48	15.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	2.36	81.66	16.05	3.30	0.94	0.47	0.47	0.00	1.42	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	0.00	61.67	12.70	1.81	0.91	0.00	0.00	0.00	0.00	1.81
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	44.23	29.48	0.00	0.00	0.00	0.00	0.00	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	1.08	74.25	10.76	1.08	0.00	1.08	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	1.27	87.66	12.70	2.54	0.00	0.00	0.00	0.00	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	0.00	164.30	49.29	0.00	0.00	0.00	0.00	0.00	0.00	16.43
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	0.64	61.22	11.48	1.91	0.64	0.00	0.00	0.64	1.28	0.64
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	1.82	58.33	7.29	1.82	1.82	0.00	0.00	0.00	0.00	5.47
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	31.61	47.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	0.71	71.41	15.00	2.14	0.00	0.00	0.00	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	0.00	59.73	6.64	0.00	0.00	3.32	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	20.85	20.85	20.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	1.23	75.93	13.58	4.32	0.31	1.23	0.62	0.31	0.31	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	0.00	42.14	5.27	1.76	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	3.14	56.58	9.43	3.14	3.14	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	0.70	49.37	9.74	0.70	0.00	0.70	0.70	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	2.21	146.06	48.69	0.00	0.00	2.21	4.43	0.00	2.21	11.07
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	55.11	35.66	0.00	3.24	0.00	3.24	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	112.48	57.55	2.62	4.36	1.74	2.62	0.87	1.74	4.36
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	11.25	150.74	74.24	4.50	4.50	2.25	4.50	0.00	0.00	11.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	3.48	135.90	55.75	0.00	6.97	0.00	3.48	3.48	0.00	10.45
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	14.93	122.68	65.07	1.07	0.00	4.27	3.20	0.00	0.00	7.47
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	2.77	83.13	26.32	2.77	0.00	0.00	2.77	0.00	1.39	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	2.85	51.29	22.80	2.85	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	3.68	80.08	23.93	3.68	1.84	0.92	0.92	0.00	0.92	0.92
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	0.00	136.14	66.56	3.03	3.03	6.05	3.03	0.00	0.00	9.08
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	6.21	161.43	62.09	0.00	0.00	0.00	6.21	6.21	0.00	12.42
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	8.46	114.20	68.73	4.23	3.17	1.06	3.17	0.00	0.00	12.69
Keratinocyte - epidermal, donor1	11272-116H3	0.16	66.91	3.02	1.47	0.00	0.24	0.00	0.24	0.08	0.00
Keratinocyte - epidermal, donor2	11349-117G8	1.17	108.34	14.64	3.51	0.00	0.59	0.00	1.17	0.59	0.00
Keratinocyte - epidermal, donor3	11421-118F8	0.38	71.65	6.53	2.46	0.00	0.47	0.00	0.09	0.57	0.00
Keratinocyte - oral, donor1	11251-116E9	0.45	77.53	5.56	3.86	0.11	0.34	0.00	0.91	0.34	0.00
Keratocytes, donor1	11527-119I6	30.26	221.43	302.23	3.44	0.69	12.38	5.16	1.03	0.00	0.00
Keratocytes, donor2	11607-120I5	0.00	48.04	17.58	4.69	0.00	1.17	0.00	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	38.73	59.28	108.68	0.40	2.17	4.54	3.75	0.20	0.40	0.79
Krukenberg tumor cell line:HSKTC	10687-109F3	0.00	50.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	2.16	37.76	3.24	1.08	0.00	2.16	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor2	11609-120I7	9.00	39.90	20.18	2.31	1.73	1.15	0.69	0.23	0.12	0.23
Lens Epithelial Cells, donor3	11690-122I7	8.27	76.19	106.36	3.63	1.61	4.24	4.14	0.20	0.10	1.01
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	403.52	68.77	145.61	37.23	13.87	9.72	14.47	5.81	1.19	1.42
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	265.96	40.47	52.75	15.63	7.81	6.70	5.30	3.07	0.84	0.56
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	340.80	45.81	93.82	31.01	10.07	9.44	10.70	3.31	1.57	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	275.85	45.17	50.01	13.44	6.99	3.76	4.84	2.69	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	213.68	36.87	55.47	18.91	7.88	5.67	3.78	0.95	0.00	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	266.73	41.08	87.01	27.28	7.76	7.65	7.76	4.31	1.51	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	304.10	45.55	73.46	28.73	9.85	5.34	5.34	2.05	2.05	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	248.77	36.66	67.00	15.93	12.39	5.31	6.32	1.52	0.51	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	283.47	44.34	91.35	29.56	9.15	7.88	12.25	3.52	2.11	0.70
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	259.87	38.37	66.45	17.01	4.35	5.93	3.56	1.98	1.19	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	263.88	36.64	68.25	16.48	9.11	7.37	4.85	1.94	0.97	0.19
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	230.88	42.95	81.84	23.51	5.74	6.85	10.37	2.96	2.04	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	281.18	44.60	71.08	22.65	6.97	6.27	5.57	2.44	1.74	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	272.63	37.93	68.69	15.98	11.69	4.77	5.01	1.67	1.43	0.48
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	291.73	40.65	86.94	25.55	7.28	8.52	9.48	3.57	1.10	0.82
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	246.67	40.34	71.75	15.71	8.31	7.70	6.47	2.16	1.54	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	257.19	30.24	58.30	15.28	11.53	7.48	3.74	2.81	0.62	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	340.73	45.75	107.23	33.49	7.32	9.15	9.15	3.48	1.83	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	281.72	47.06	68.78	17.77	7.57	8.23	5.92	3.62	0.99	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	306.93	34.56	59.45	16.69	11.42	5.56	1.46	1.17	1.17	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	380.11	44.56	94.34	25.39	7.47	13.19	7.72	4.98	1.99	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	249.76	53.35	56.74	21.82	6.79	4.85	2.91	2.42	1.94	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	224.59	31.24	51.97	12.39	9.43	2.96	3.77	1.35	0.81	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	288.98	44.51	95.37	24.83	10.60	8.63	8.93	3.03	2.42	0.91
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	294.46	36.81	62.73	14.00	7.78	6.22	9.33	2.59	1.04	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	222.58	35.60	51.72	13.40	6.91	6.07	3.98	2.09	0.84	0.42
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	279.09	36.84	96.09	21.35	9.02	8.57	10.83	4.51	1.35	0.90
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	235.94	46.78	50.21	18.57	5.50	6.19	4.82	2.75	0.00	0.69
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	202.64	33.68	67.17	11.85	9.22	3.57	5.64	1.51	2.07	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	264.65	40.29	107.30	24.39	9.12	9.86	8.38	2.86	1.59	0.64
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	224.36	42.16	74.62	14.54	5.81	2.42	5.81	1.45	0.00	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	220.97	31.42	57.89	9.59	9.59	3.31	4.63	1.98	1.65	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	280.24	38.53	109.77	28.37	8.67	9.17	11.52	3.96	1.61	0.87
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	302.83	47.02	124.39	27.77	8.89	10.37	10.37	4.44	1.85	0.74
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	239.18	37.56	47.44	12.85	9.64	5.93	3.21	1.73	1.24	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	259.86	45.37	92.95	23.92	9.49	6.46	9.21	2.61	1.37	0.27
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	261.17	43.42	82.34	24.12	7.72	8.04	6.75	2.57	2.57	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	279.37	39.26	61.78	11.56	8.83	3.96	5.17	1.52	1.83	0.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	258.94	43.95	112.67	26.59	7.70	9.80	12.04	4.76	1.68	0.98
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	214.76	43.02	80.36	17.42	6.76	10.31	8.18	2.13	1.07	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	223.48	34.42	58.17	12.60	10.67	6.30	2.91	2.91	0.48	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	276.36	41.08	113.44	22.25	9.65	10.27	12.14	2.80	1.71	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	220.59	42.97	72.70	18.98	6.80	7.52	7.16	2.51	0.36	0.00
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	211.03	39.20	53.90	9.80	8.49	1.96	5.55	0.98	1.31	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	228.83	38.84	92.52	24.01	7.77	9.65	10.83	2.83	2.12	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	322.62	70.04	162.61	33.41	11.51	12.87	20.17	5.57	1.36	1.49
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	181.59	31.76	50.97	8.45	5.63	3.84	3.84	1.02	0.77	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	242.56	35.21	96.97	18.80	8.95	8.35	12.83	2.09	1.49	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	2.27	40.79	2.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	0.77	29.15	2.30	0.00	0.00	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	2.97	30.43	0.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	2.12	37.24	0.85	0.42	0.00	0.00	0.42	0.00	0.42	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	2.11	26.02	0.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	1.87	28.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	2.58	25.25	1.03	0.52	0.00	0.00	0.00	0.00	1.03	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	0.00	21.41	1.19	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	0.90	36.19	1.36	0.00	0.23	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	2.62	41.01	0.87	0.00	0.00	0.00	0.00	0.00	0.29	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	1.80	35.11	3.15	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	2.03	43.76	1.90	0.00	0.00	0.14	0.14	0.00	0.14	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	1.54	34.92	0.51	0.00	0.00	0.51	0.00	0.00	0.51	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	3.18	33.87	1.76	0.35	0.00	0.00	0.00	0.35	0.35	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	1.33	25.99	1.33	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	3.57	30.56	1.02	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	4.80	36.29	0.53	0.27	0.00	0.00	0.53	0.00	0.27	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	2.65	39.49	2.08	0.57	0.00	0.00	0.00	0.00	0.57	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	2.45	34.36	0.61	1.23	0.00	0.00	0.61	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	2.45	41.59	0.82	0.82	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	2.50	38.94	2.50	0.21	0.21	0.00	0.00	0.00	0.21	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	3.08	35.59	2.24	0.56	0.56	0.00	0.00	0.00	0.84	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	6.18	38.12	1.03	1.03	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	4.35	39.48	2.03	0.29	0.29	0.00	0.29	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	1.79	32.28	0.60	0.90	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	1.66	37.62	1.66	0.55	0.00	0.00	0.00	0.00	0.55	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	4.24	36.76	1.41	0.35	0.35	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	4.06	39.46	1.48	1.11	0.00	0.00	0.37	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	2.30	28.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	3.07	32.62	2.30	0.38	0.00	0.00	0.00	0.00	0.38	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	3.40	41.89	1.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	1.64	41.84	1.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	0.45	36.15	4.52	1.36	0.00	0.00	0.00	0.00	0.45	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	5.75	34.47	2.87	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	3.73	41.83	2.24	0.75	0.00	0.00	0.00	0.00	0.75	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	2.23	49.05	1.86	0.37	0.00	0.00	0.00	0.00	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.03	38.77	1.29	1.29	0.00	0.00	0.00	0.00	0.43	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	5.99	59.08	2.57	0.00	0.00	0.00	0.00	0.86	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	5.00	40.98	1.00	0.33	0.00	0.33	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	7.84	39.82	0.60	1.81	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	3.55	36.97	2.84	1.42	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	4.12	39.53	3.44	0.34	0.34	0.00	0.34	0.00	1.37	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	4.83	39.72	1.61	0.54	0.00	0.00	0.54	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	4.04	35.01	0.67	0.67	0.00	0.00	0.00	0.00	0.67	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	4.07	40.00	3.70	1.85	0.00	0.37	0.37	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	3.49	26.75	4.65	0.00	0.00	0.00	0.00	0.00	0.00	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	5.29	26.44	3.17	2.12	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	4.00	42.02	2.40	0.40	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	0.73	39.25	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	3.07	39.09	0.00	0.77	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	2.47	36.01	1.97	0.99	0.00	0.00	0.49	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	3.76	32.93	0.94	0.00	0.00	0.94	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	2.51	37.21	1.01	0.50	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	1.35	33.80	0.90	0.00	0.00	0.00	0.00	0.00	0.90	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	0.00	18.93	8.61	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	2.67	37.41	4.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	3.13	44.58	2.74	0.39	0.00	0.00	0.39	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	4.62	32.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	2.59	37.88	3.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	2.63	56.88	1.75	0.44	0.00	0.00	0.00	0.00	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	1.12	38.58	2.24	0.56	0.00	0.00	0.56	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	2.65	46.81	0.88	0.00	0.00	0.44	0.44	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	1.54	42.81	2.70	0.00	0.00	0.00	0.39	0.00	0.39	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	3.54	37.98	3.04	0.51	0.00	0.51	0.51	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	2.40	47.10	1.92	0.48	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	3.58	40.95	1.99	0.00	0.00	0.00	0.40	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	2.43	30.38	3.04	0.61	0.00	1.22	0.00	1.22	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	1.38	33.89	1.38	0.69	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	4.18	43.32	2.28	1.14	0.00	0.38	0.00	0.00	1.52	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	5.68	37.70	2.07	1.03	0.00	0.00	0.52	0.52	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	4.23	41.72	4.23	1.81	0.00	0.00	0.00	0.00	0.60	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	3.17	45.32	2.22	0.95	0.00	0.63	0.32	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	3.73	46.38	3.20	3.20	0.00	0.00	1.07	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	3.45	44.25	1.72	1.15	0.00	0.57	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	2.06	46.80	3.09	1.03	0.51	0.00	0.51	0.00	0.51	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	7.07	55.88	4.24	4.24	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	5.11	56.75	2.84	1.13	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	3.33	45.35	5.41	0.83	0.00	0.00	0.00	0.83	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	6.26	49.33	1.57	2.35	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	2.09	52.61	3.34	2.51	0.00	0.00	0.00	0.00	0.42	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	6.50	41.35	2.79	0.46	0.00	0.00	0.00	0.00	0.93	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	6.02	55.53	4.68	2.01	0.00	0.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	3.74	64.69	4.28	1.60	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	6.47	52.94	6.06	5.25	0.00	0.40	0.00	0.00	0.40	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	10.10	46.81	6.42	2.75	0.00	0.00	1.84	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	7.11	58.68	1.78	4.45	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	3.99	43.31	5.70	5.13	0.00	0.57	0.00	1.14	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	7.67	44.48	3.07	2.30	0.00	0.77	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	8.75	65.11	3.83	4.38	0.00	0.00	0.00	0.55	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	12.47	56.13	7.13	2.67	0.00	0.00	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	7.28	77.47	13.26	6.76	0.00	0.78	0.52	1.04	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	8.62	65.65	5.30	3.98	0.66	0.00	1.33	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	14.55	29.10	4.16	4.16	0.00	0.00	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	5.70	26.89	4.56	3.87	0.46	0.91	0.23	0.00	0.00	0.00
Macrophage - monocyte derived, donor2	11313-117C8	53.77	144.79	55.60	42.02	2.75	4.59	8.62	6.79	0.18	0.37
Macrophage - monocyte derived, donor3	11389-118C3	14.42	68.03	25.04	16.39	1.57	1.97	3.15	2.23	0.66	0.26
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	0.00	32.39	1.06	2.12	0.00	0.00	0.00	0.53	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	0.79	63.22	1.58	1.43	0.00	0.00	0.00	0.00	0.16	0.00
Mallassez-derived cells, donor3	11930-125I4	0.56	77.14	3.20	2.64	0.00	0.28	0.00	0.14	0.00	0.00
Mammary Epithelial Cell, donor1	11273-116H4	0.40	92.07	16.74	11.16	0.00	1.30	0.10	0.20	0.00	0.00
Mammary Epithelial Cell, donor2	11350-117G9	0.87	98.74	14.77	4.92	0.29	1.16	0.00	1.16	0.29	0.00
Mammary Epithelial Cell, donor3	11422-118F9	0.50	39.41	4.24	2.49	0.00	0.00	0.00	0.50	0.00	0.00
Mast cell - stimulated, donor1	11487-119E2	381.68	299.65	402.69	45.42	3.39	18.30	73.90	4.75	0.68	6.10
Mast cell, donor1	11563-120D6	16.55	74.83	49.96	14.27	0.97	3.68	1.73	0.43	0.87	0.87
Mast cell, donor2	11565-120D8	2.67	66.86	4.16	0.89	0.30	0.30	1.19	0.00	0.00	0.30
Mast cell, donor3	11566-120D9	1.35	48.63	0.45	0.00	0.23	0.00	0.00	0.00	0.00	0.00
Mast cell, donor4	11567-120E1	2.48	53.01	1.60	0.71	0.18	0.53	0.00	0.35	0.71	0.00
Mast cell, expanded and stimulated, donor5	11940-126A5	14.97	144.72	80.18	31.27	1.00	9.65	2.22	1.66	0.89	0.22
Mast cell, expanded and stimulated, donor8	11942-126A7	21.01	162.26	99.81	36.19	0.00	8.76	0.58	3.50	1.17	0.00
Mast cell, expanded, donor5	11939-126A4	7.11	40.27	20.08	14.80	0.46	1.84	0.11	0.69	0.23	0.00
Mast cell, expanded, donor8	11941-126A6	0.67	25.77	5.69	5.52	0.17	0.17	0.00	0.00	0.33	0.00
Melanocyte - dark, donor1	11502-119F8	56.91	56.42	177.70	70.05	6.77	19.80	21.39	10.45	0.50	0.70
Melanocyte - dark, donor2	11582-120F7	40.15	42.57	44.64	5.19	3.46	2.42	2.77	1.04	0.69	0.00
Melanocyte - dark, donor3	11663-122F7	128.15	98.81	41.36	1.59	15.36	0.72	1.52	0.14	0.14	0.36
Melanocyte - light, donor1	11274-116H5	208.74	85.33	35.50	3.53	15.04	1.41	0.71	0.00	0.47	0.24
Melanocyte - light, donor2	11351-117H1	293.46	51.87	18.43	2.73	14.33	0.68	0.00	0.00	0.68	0.68
Melanocyte - light, donor3	11423-118G1	52.03	37.29	17.34	2.60	6.07	0.87	0.00	0.00	0.87	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	45.40	61.43	9.48	0.73	4.27	0.21	0.62	0.00	0.94	0.10
Melanocyte, donor2 (MC+2)	12739-135I3	223.49	77.99	25.82	0.27	16.41	0.00	1.61	0.00	1.08	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	768.74	92.41	59.46	0.54	33.21	0.27	2.68	0.27	1.34	1.07
Meningeal Cells, donor1	11493-119E8	1.24	167.36	27.42	7.44	0.12	1.24	0.12	0.25	0.25	0.00
Meningeal Cells, donor2	11573-120E7	4.84	146.13	49.74	4.84	1.32	0.44	0.44	0.00	0.00	0.00
Meningeal Cells, donor3	11654-122E7	0.00	67.32	12.14	3.99	0.16	0.49	0.00	0.24	0.00	0.00
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	0.00	54.75	8.84	2.57	0.57	1.43	0.00	0.29	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	3.12	51.93	58.67	7.35	0.50	3.42	1.61	0.50	0.20	0.50
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	13.14	11.83	5.26	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	0.00	32.70	9.16	1.31	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	2.15	55.97	2.15	3.59	0.00	0.00	0.00	0.00	1.44	0.00
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	38.54	52.52	70.10	7.20	5.29	1.48	2.33	0.21	1.06	1.48
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	14.07	45.24	31.67	4.02	1.51	2.51	1.51	0.00	1.01	1.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	0.44	90.76	6.81	3.52	0.22	0.66	0.00	0.22	0.22	0.22
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	0.00	68.68	1.46	1.46	0.00	0.73	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	0.00	61.59	1.23	2.05	0.00	0.61	0.20	0.00	0.20	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	2.08	32.41	8.45	2.91	0.28	0.55	0.14	0.28	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	0.74	34.94	18.21	2.60	0.00	0.37	0.37	0.37	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	7.24	57.63	141.57	9.21	1.32	6.18	1.97	1.05	0.53	0.39
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	0.89	26.41	15.13	2.67	0.00	1.19	0.30	0.00	0.89	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	7.01	44.38	60.72	2.34	0.00	0.00	4.67	0.00	0.00	2.34
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	0.64	58.92	12.17	2.56	0.00	1.28	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	0.35	89.32	9.57	4.96	0.00	1.77	0.00	0.00	0.00	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	3.75	54.10	119.46	10.01	0.31	5.00	0.94	0.31	0.00	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	0.00	42.82	1.45	4.35	0.00	0.00	0.00	0.00	0.73	0.00
Mesothelial Cells, donor1	11247-116E5	5.83	37.39	22.81	3.98	1.86	1.06	0.27	0.53	0.00	0.27
Mesothelial Cells, donor2	12156-128G5	4.00	24.02	26.52	0.50	1.00	0.50	1.00	0.00	0.00	0.00
Mesothelial Cells, donor3	11402-118D7	2.60	25.00	6.87	1.30	0.22	0.22	0.22	0.07	0.07	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	17.55	78.32	20.25	13.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	12.56	82.26	37.19	22.16	0.25	2.96	3.94	2.96	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	35.92	108.07	60.66	29.45	1.77	6.48	8.24	5.01	0.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	34.57	3.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	13.95	65.09	19.84	16.74	0.62	2.48	3.41	3.10	0.31	0.31
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	31.32	92.10	52.07	29.87	2.07	2.90	5.60	4.77	0.21	0.41
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	41.69	0.00	2.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	22.52	78.08	47.05	26.03	2.00	4.00	5.01	2.00	0.50	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	29.33	100.54	47.48	22.81	1.86	3.72	2.79	3.72	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	17.68	76.61	41.66	22.76	2.24	3.45	4.06	3.25	0.61	0.20
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	30.09	88.70	45.54	28.11	1.58	6.34	3.17	3.17	0.79	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	51.31	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	39.82	62.83	30.97	9.73	2.65	0.88	1.77	0.88	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	35.71	118.54	67.25	31.15	3.42	3.42	6.46	3.04	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	7.90	35.53	1.32	2.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	54.33	70.25	33.53	19.52	2.55	2.97	2.33	3.82	0.64	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	28.55	58.01	11.97	15.65	0.92	4.60	0.92	1.84	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	63.19	58.42	20.57	17.88	3.87	0.60	1.79	1.19	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	18.44	88.86	8.38	1.68	0.00	3.35	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	33.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	241.12	68.75	32.12	17.81	3.76	1.76	3.01	2.51	0.50	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	145.93	86.51	38.50	22.34	3.09	2.61	3.80	3.80	0.48	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	180.79	65.24	3.87	5.53	0.55	0.55	0.55	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	915.23	77.59	35.00	23.02	5.07	4.14	3.91	2.76	0.92	0.46
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	242.10	101.80	58.68	22.72	3.58	4.84	7.99	3.16	0.84	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	584.17	74.19	22.42	12.64	3.06	3.06	2.24	1.63	1.02	0.61
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	734.80	69.30	32.18	20.38	5.15	3.43	3.65	1.72	0.64	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	525.27	101.59	37.79	17.78	2.67	4.00	3.78	3.11	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	144.46	30.96	10.32	10.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	1276.21	73.59	29.79	15.77	5.26	1.97	2.63	0.88	2.19	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	472.48	97.34	22.81	11.66	2.53	1.52	1.52	2.03	0.51	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	318.14	51.37	3.31	0.00	0.00	1.66	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	1360.86	75.29	25.00	9.78	7.88	2.99	1.09	2.72	1.09	0.27
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	1101.63	105.28	41.17	20.59	8.23	1.76	3.23	3.23	1.18	0.88
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	413.23	70.87	4.36	3.27	4.36	1.09	1.09	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	1550.27	92.27	33.64	17.78	14.90	0.96	2.88	0.96	1.44	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	1829.45	123.67	36.42	22.41	9.21	5.60	4.40	3.60	2.80	1.20
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	682.87	89.13	5.48	4.11	6.86	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	2086.41	98.11	28.53	14.02	14.02	3.50	2.50	3.00	5.01	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	2883.35	161.68	26.95	53.89	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	591.17	75.42	4.08	4.08	6.12	2.04	2.04	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	2816.71	118.68	18.39	9.20	22.77	1.31	0.88	2.63	2.19	1.31
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	659.98	100.43	9.93	4.41	7.73	2.21	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	721.08	92.86	10.89	3.20	7.68	0.64	1.28	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	3468.39	128.42	32.23	10.91	21.57	0.74	1.98	1.98	4.21	0.50
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	918.58	103.69	14.61	6.96	7.65	1.39	2.78	2.78	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	559.10	75.14	4.42	6.63	6.63	0.00	2.21	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	2265.96	101.54	29.40	6.50	30.09	1.03	1.03	2.05	4.79	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	1242.83	101.09	13.57	3.94	7.44	1.31	3.06	0.00	0.44	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	584.13	77.06	2.84	2.49	3.20	1.42	0.36	0.36	0.00	0.71
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	2109.47	124.56	27.77	10.66	28.62	2.24	2.52	0.84	4.49	1.12
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1474.23	120.95	10.81	7.48	14.96	1.25	0.83	0.42	0.83	0.42
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	477.85	76.92	9.91	2.33	6.99	1.17	0.58	0.00	0.58	1.17
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	1387.96	95.63	23.23	7.54	20.51	1.81	3.92	1.21	2.41	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	2240.97	114.37	25.04	13.77	27.97	1.67	1.25	0.83	2.92	0.42
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	433.13	36.09	0.00	7.22	7.22	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	1041.77	96.97	22.17	5.54	15.70	1.85	1.85	0.92	1.85	0.92
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	2006.71	138.30	19.92	9.11	25.61	1.71	0.57	0.57	1.71	0.57
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	796.20	74.20	18.10	5.11	15.48	1.80	1.38	0.41	0.97	0.83
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	1493.21	94.85	34.47	9.59	26.17	1.81	3.11	1.30	2.85	1.55
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	1696.17	129.12	17.16	6.86	15.44	0.86	1.29	0.43	1.29	0.43
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	374.76	57.17	4.45	0.64	9.53	2.54	1.27	0.00	0.00	1.91
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	798.80	69.39	21.62	4.80	20.55	1.87	1.33	0.27	0.80	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	832.14	109.26	47.29	22.15	12.57	3.29	5.09	2.99	0.30	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	375.88	50.71	12.85	5.37	8.62	0.99	0.99	0.28	0.57	0.28
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	1320.56	78.99	26.44	7.64	28.67	1.91	2.23	1.27	2.87	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	2075.98	120.52	28.08	11.50	30.52	1.11	2.43	1.55	1.33	1.11
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	527.85	56.12	14.79	4.17	12.51	1.90	1.52	0.76	0.00	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	1065.40	70.46	37.22	12.22	24.43	2.84	2.27	1.14	1.14	2.27
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	1994.94	118.97	33.43	13.03	34.66	4.67	3.69	1.97	4.92	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	72.99	39.75	7.17	3.26	3.26	0.65	1.30	0.65	0.00	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	458.39	53.22	35.58	12.94	15.58	2.65	2.35	1.47	1.76	1.47
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	503.13	88.23	40.37	18.74	12.11	3.17	5.48	1.44	1.15	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	111.28	58.52	51.52	20.61	7.01	2.47	4.12	2.06	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	205.47	51.22	27.10	16.68	9.23	2.08	2.08	0.60	0.60	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	0.00	26.37	3.77	11.30	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	10.69	26.73	16.04	12.48	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.80	36.47	6.57	7.89	0.66	1.31	0.66	0.66	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	28.40	64.17	21.04	15.78	1.05	1.05	1.05	1.05	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	24.12	41.71	18.58	16.01	0.99	2.17	0.59	1.98	0.40	0.20
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	78.23	67.06	137.84	29.80	0.00	13.04	4.66	3.73	0.93	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	42.06	43.19	39.06	22.91	2.25	2.63	0.75	4.13	0.75	0.38
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	42.35	93.75	42.61	30.63	1.86	4.79	4.26	4.53	0.53	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	9.61	31.44	5.32	7.24	0.57	0.34	0.23	0.90	0.00	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	28.73	38.31	17.68	13.26	0.00	1.47	0.00	2.21	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	10.26	25.65	5.13	5.50	0.00	0.37	0.37	1.10	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	26.45	70.00	18.67	31.11	1.56	3.11	1.56	0.00	1.56	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	152.31	32.60	5.34	12.83	1.07	1.07	0.00	1.60	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	239.56	42.50	15.46	19.32	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	67.67	38.38	11.11	6.06	0.00	1.01	1.01	3.03	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	67.88	72.94	24.88	11.38	1.69	1.69	1.69	2.95	0.42	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	618.32	51.75	5.45	2.72	4.09	0.00	1.36	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1387.94	59.76	14.62	12.08	4.45	1.27	0.64	0.00	0.64	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1630.20	87.46	4.05	8.10	5.67	0.00	0.81	1.62	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	219.01	40.78	6.04	7.55	0.00	1.51	0.00	1.51	1.51	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	2038.53	177.02	0.00	11.42	17.13	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	4156.36	192.48	35.89	45.67	16.31	6.52	0.00	6.52	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	3250.69	118.81	4.75	4.75	28.51	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	376.47	112.94	12.55	12.55	25.10	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	4.96	84.45	120.00	10.34	0.86	4.52	3.23	0.22	0.86	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	12.02	42.33	112.36	5.75	2.61	4.18	4.18	1.57	1.05	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	0.00	13.35	0.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	0.42	12.94	0.42	0.42	0.00	0.42	0.00	0.42	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	0.19	30.23	4.37	2.66	0.00	0.95	0.19	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	0.00	36.70	0.00	0.00	0.00	1.60	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	0.00	10.20	0.00	0.68	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	0.00	31.24	3.68	3.68	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	1.26	8.79	0.84	0.42	0.00	0.00	0.42	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	0.00	20.45	0.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	1.62	15.40	2.97	0.27	0.00	0.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	5.68	19.97	3.15	1.89	0.21	0.21	0.00	0.00	0.00	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	0.00	77.94	44.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	1.49	9.93	1.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	0.27	12.45	1.08	1.35	0.00	0.27	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	2.04	10.88	0.91	0.23	0.00	0.00	0.00	0.00	0.23	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	0.49	11.59	2.45	1.31	0.33	0.33	0.16	0.00	0.33	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	5.65	17.86	3.46	3.10	0.18	0.36	0.00	0.00	0.18	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	1.06	12.20	1.06	1.59	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	1.80	7.20	0.00	0.00	0.60	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	1.31	18.71	2.63	1.31	0.00	0.00	0.00	0.66	0.00	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	0.00	8.13	1.95	0.33	0.00	0.16	0.00	0.00	0.16	0.00
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	1.94	15.52	3.88	1.41	0.53	0.18	0.18	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	0.00	9.85	2.11	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	0.00	11.49	0.46	0.92	0.00	0.00	0.00	0.46	0.46	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	1.29	14.14	1.61	0.96	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	2.07	27.25	11.04	2.07	1.03	1.38	0.34	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	0.00	50.57	146.65	7.59	5.06	5.06	2.53	0.00	0.00	2.53
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	1.78	14.93	3.79	2.67	0.89	0.45	0.00	0.22	0.00	0.22
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	0.00	13.13	3.39	1.69	0.00	0.00	0.85	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	0.47	10.21	1.19	1.42	0.00	0.24	0.00	0.00	0.47	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	3.43	19.32	8.58	3.00	0.00	1.29	0.43	0.43	0.86	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	9.03	99.31	180.56	27.08	9.03	0.00	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	2.33	16.66	8.66	2.33	0.67	0.33	0.00	0.00	0.67	0.00
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	0.90	15.33	5.86	0.90	0.90	0.45	0.45	0.00	0.45	0.45
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	1.19	17.86	10.71	2.38	0.79	0.40	0.00	0.79	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	0.93	12.07	2.79	0.93	0.00	0.93	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	1.14	23.84	11.35	1.89	0.00	0.76	0.38	0.00	1.14	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.24	16.29	11.08	2.93	0.33	0.65	0.33	0.00	0.33	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	1.31	17.43	6.97	3.05	0.44	0.44	0.00	0.44	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	0.45	17.64	10.40	2.71	0.00	0.00	0.00	0.45	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	0.88	14.11	13.23	3.53	1.76	0.88	0.88	0.00	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	0.00	7.98	3.32	1.33	1.33	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	0.99	19.84	3.97	1.98	0.00	0.99	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	1.53	20.67	10.34	0.77	1.15	0.38	0.38	0.00	0.38	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	2.12	34.18	24.50	4.23	0.60	1.21	1.21	0.30	0.60	0.60
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	2.21	23.65	20.33	2.21	1.11	1.11	0.22	0.22	0.22	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	2.71	11.52	5.42	3.39	0.00	1.36	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	15.33	30.66	25.55	10.22	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	0.61	16.46	5.49	4.27	0.00	1.22	0.00	1.22	0.00	0.61
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	0.31	22.03	16.05	2.20	0.31	0.00	0.63	0.31	0.31	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	2.12	14.83	4.24	2.12	0.00	0.00	0.30	0.30	0.30	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	0.79	14.24	3.96	0.79	0.00	0.00	0.00	0.79	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	4.53	34.01	58.95	7.94	0.00	1.13	2.27	1.13	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	0.00	20.23	35.41	5.06	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	8.32	47.08	10.93	3.11	0.12	1.12	0.25	0.62	0.12	0.12
Myoblast, donor2	11322-117D8	0.58	46.80	7.10	3.84	0.19	0.77	0.19	0.00	0.38	0.19
Myoblast, donor3	11398-118D3	0.17	38.34	2.02	1.35	0.00	0.67	0.00	0.00	0.00	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	61.15	101.72	48.74	2.48	7.00	0.58	1.61	0.15	0.73	6.86
Natural Killer Cells, donor1	11230-116C6	14.76	51.05	4.92	0.92	0.62	0.00	0.00	0.62	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	1.51	29.55	0.60	0.00	0.30	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	12.33	37.92	1.47	0.74	0.37	0.18	0.18	0.00	0.18	0.00
Neural stem cells, donor1	11275-116H6	2.90	49.00	3.63	1.09	0.36	0.00	0.00	0.00	0.00	0.00
Neural stem cells, donor2	11352-117H2	7.70	73.17	1.93	0.00	1.93	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	9.10	45.52	3.41	1.14	0.00	0.00	0.00	0.00	0.00	0.00
Neurons, donor2	11574-120E8	6.16	42.93	2.42	0.44	0.66	0.44	0.00	0.00	0.22	0.00
Neurons, donor3	11655-122E8	5.76	31.24	0.00	2.47	0.00	1.64	0.00	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	171.68	220.87	17.63	12.99	6.50	0.93	0.93	2.78	1.86	0.93
Neutrophils, donor2	11314-117C9	69.57	107.26	8.70	2.90	2.90	0.00	0.00	0.00	2.90	0.00
Neutrophils, donor3	11390-118C4	254.72	284.04	38.48	15.88	9.16	0.00	3.05	3.05	1.22	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	1.31	22.08	4.39	1.31	0.12	0.36	0.00	0.00	0.12	0.12
Nucleus Pulposus Cell, donor2	11409-118E5	0.65	12.37	7.16	1.30	0.00	0.33	0.33	0.00	0.65	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	3.01	50.54	28.68	3.41	0.60	1.20	0.20	0.00	0.40	0.00
Olfactory epithelial cells, donor1	11933-125I7	17.34	23.95	93.60	1.93	4.40	3.03	4.54	0.00	0.96	0.69
Olfactory epithelial cells, donor2	11934-125I8	6.08	53.85	80.48	3.76	0.72	3.47	2.89	0.58	2.17	0.58
Olfactory epithelial cells, donor3	11935-125I9	5.79	46.88	74.23	4.88	1.48	2.84	2.72	0.57	0.34	0.11
Olfactory epithelial cells, donor4	11936-126A1	6.53	35.94	66.72	3.99	1.17	2.53	1.17	0.10	0.29	0.10
Oligodendrocyte - precursors, donor1	11496-119F2	3.61	105.32	50.55	4.21	0.60	1.20	0.60	0.00	0.00	0.00
Osteoblast - differentiated, donor1	11276-116H7	4.47	47.22	40.62	6.59	0.43	2.13	1.49	0.85	0.00	0.00
Osteoblast - differentiated, donor2	11353-117H3	2.29	21.72	32.01	2.29	0.00	1.14	3.43	0.00	2.29	0.00
Osteoblast - differentiated, donor3	11425-118G3	2.48	30.41	31.04	1.24	1.86	1.86	0.00	0.00	1.24	1.24
Osteoblast, donor1	11277-116H8	1.76	84.23	67.62	5.08	0.20	4.89	1.56	0.20	0.39	0.39
Osteoblast, donor2	11354-117H4	2.11	100.43	38.63	7.02	0.00	3.51	0.00	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	0.53	52.96	20.44	4.27	0.36	2.13	0.71	0.18	0.00	0.53
Pancreatic stromal cells, donor1	11249-116E7	5.31	58.80	34.87	6.40	0.76	1.52	1.01	0.42	0.76	0.51
Pericytes, donor1	11491-119E6	1.67	45.84	9.35	1.11	0.22	0.33	0.11	0.00	0.11	0.00
Pericytes, donor2	11571-120E5	2.26	44.37	11.09	1.36	0.45	0.00	0.91	0.00	0.23	0.00
Pericytes, donor3	11652-122E5	4.27	75.68	86.06	9.77	0.41	4.27	1.02	1.02	0.61	0.41
Perineurial Cells, donor1	11499-119F5	5.09	67.81	64.42	6.67	0.68	2.15	0.79	0.90	0.11	0.57
Perineurial Cells, donor2	11579-120F4	45.82	66.52	89.34	5.89	4.97	3.77	2.94	0.83	0.09	0.74
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	89.57	74.90	37.29	17.53	1.27	1.27	1.59	0.64	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	186.10	66.85	24.24	11.02	7.35	0.73	1.22	1.47	0.49	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	126.96	64.32	10.74	6.21	2.59	0.39	1.42	0.78	0.13	0.00
Placental Epithelial Cells, donor1	11278-116H9	0.00	50.46	3.59	1.67	0.00	0.00	0.00	0.00	0.24	0.00
Placental Epithelial Cells, donor2	11355-117H5	0.00	48.79	15.52	7.76	0.00	1.11	0.00	1.11	1.11	0.00
Placental Epithelial Cells, donor3	11427-118G5	0.00	36.32	13.35	3.93	0.00	0.98	0.20	0.20	0.39	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	0.00	29.11	19.62	8.54	0.32	1.58	0.00	0.32	0.95	0.00
Preadipocyte - breast, donor1	11467-119B9	7.13	33.77	77.10	12.19	1.69	5.82	0.94	1.31	1.13	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	4.44	75.44	126.35	15.14	1.17	8.35	3.13	1.96	0.78	0.91
Preadipocyte - breast, donor2	11328-117E5	2.25	48.18	45.03	9.68	0.45	1.58	1.35	0.68	1.35	0.45
Preadipocyte - omental, donor1	11468-119C1	11.93	52.00	131.60	7.25	4.37	7.14	3.94	0.96	0.75	0.53
Preadipocyte - omental, donor2	11329-117E6	3.06	41.03	51.94	8.73	0.44	2.62	2.18	0.87	0.44	1.75
Preadipocyte - omental, donor3	11403-118D8	2.72	50.42	53.43	6.59	0.57	1.86	1.72	0.29	0.72	0.43
Preadipocyte - perirenal, donor1	11469-119C2	2.95	41.34	12.80	2.95	0.00	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	3.69	60.50	18.43	7.99	0.31	0.92	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	4.96	69.77	3.36	2.66	0.00	0.53	0.00	0.00	0.35	0.18
Preadipocyte - subcutaneous, donor3	11428-118G6	3.07	49.38	24.69	7.66	0.34	1.53	1.02	0.34	0.85	0.68
Preadipocyte - visceral, donor1	11280-116I2	5.96	46.01	10.43	3.63	0.56	1.49	0.09	0.19	0.09	0.19
Preadipocyte - visceral, donor2	11357-117H7	8.28	62.58	11.50	5.98	1.84	0.92	1.38	0.92	0.92	0.00
Preadipocyte - visceral, donor3	11429-118G7	2.09	42.42	1.57	1.78	0.00	0.63	0.00	0.00	0.21	0.00
Prostate Epithelial Cells (polarized), donor1	11253-116F2	1.51	41.94	5.43	0.45	0.00	0.30	0.15	0.15	0.75	0.00
Prostate Epithelial Cells, donor2	11331-117E8	0.41	33.99	0.81	0.27	0.00	0.00	0.00	0.00	0.54	0.00
Prostate Epithelial Cells, donor3	11404-118D9	0.92	39.50	21.68	2.51	0.06	0.92	0.49	0.31	0.37	0.00
Prostate Stromal Cells, donor1	11254-116F3	106.27	146.59	260.83	7.97	9.11	8.43	12.87	0.80	1.94	1.94
Prostate Stromal Cells, donor2	11332-117E9	22.23	99.33	96.82	5.56	2.69	5.02	1.79	0.54	1.26	0.54
Prostate Stromal Cells, donor3	11405-118E1	33.47	36.60	112.62	3.96	6.99	2.40	9.80	0.42	2.29	1.67
Renal Cortical Epithelial Cells, donor1	11516-119H4	9.12	117.89	30.66	7.30	0.36	1.46	0.00	1.09	0.36	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	1.80	65.78	15.87	5.27	0.28	1.59	0.07	0.55	0.28	0.07
Renal Epithelial Cells, donor1	11517-119H5	1.01	57.32	5.58	2.03	0.00	0.51	0.00	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	0.00	39.83	7.82	1.42	0.00	0.00	0.00	0.00	0.71	0.00
Renal Epithelial Cells, donor3	11678-122H4	0.21	42.35	3.71	1.48	0.11	0.00	0.11	0.00	0.21	0.00
Renal Glomerular Endothelial Cells, donor1	11514-119H2	47.66	32.68	40.85	14.30	6.13	0.68	2.04	1.36	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	45.95	64.69	63.20	8.09	3.23	3.37	1.75	2.43	0.81	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	30.19	38.63	52.39	7.33	3.11	2.66	3.33	0.22	0.44	0.67
Renal Glomerular Endothelial Cells, donor4	11783-124B1	68.54	12.64	59.22	9.32	5.99	2.66	3.33	2.66	0.00	1.33
Renal Mesangial Cells, donor1	11518-119H6	0.88	80.55	12.32	3.52	0.44	1.32	0.00	0.00	0.44	0.00
Renal Mesangial Cells, donor2	11598-120H5	1.88	64.58	14.42	3.13	0.63	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	3.05	37.45	7.21	0.83	0.55	0.55	0.00	0.00	0.00	0.55
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	10.74	180.38	29.79	10.20	0.54	1.34	0.27	0.54	0.54	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	10.12	115.97	30.78	7.17	0.42	0.84	0.42	0.84	0.84	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	2.89	63.25	12.92	1.93	0.19	0.58	0.00	0.00	0.58	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	1.04	49.78	7.78	1.04	0.26	1.30	0.26	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	0.00	36.95	3.98	1.42	0.00	0.00	0.00	0.00	0.28	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	0.00	61.75	6.17	2.06	0.00	1.03	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	2.76	119.18	89.07	3.26	0.00	5.02	0.50	1.00	0.25	0.00
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	117.73	26.73	38.49	11.36	1.47	1.87	9.76	0.94	1.34	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	18.76	24.12	36.63	6.25	0.89	0.89	0.89	0.89	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	65.49	45.68	132.09	17.06	2.20	4.95	0.00	0.00	1.10	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	19.72	22.62	40.02	5.22	1.16	2.32	0.00	1.74	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	0.78	34.07	2.60	1.82	0.26	0.13	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	0.00	20.85	3.77	1.79	0.00	0.50	0.00	0.10	0.30	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	0.56	24.65	6.58	1.45	0.33	0.45	0.11	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	0.25	38.58	6.33	2.60	0.00	0.37	0.00	0.12	0.25	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	0.23	24.59	4.08	1.28	0.00	0.12	0.00	0.12	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	0.00	27.04	2.54	1.16	0.00	0.23	0.00	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	0.14	19.71	2.88	2.33	0.00	0.27	0.00	0.14	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	0.15	19.82	4.08	1.82	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	0.00	21.32	5.20	0.72	0.18	0.18	0.00	0.18	0.36	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	0.43	22.95	3.16	1.86	0.00	0.43	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	0.11	20.82	3.00	1.29	0.00	0.43	0.00	0.11	0.11	0.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	0.66	18.37	3.10	1.55	0.00	0.22	0.00	0.22	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	1.15	24.47	2.87	1.53	0.00	0.19	0.00	0.00	0.38	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	0.37	23.66	2.89	1.30	0.00	0.19	0.00	0.19	0.19	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	0.94	24.24	9.21	2.07	0.00	0.56	0.00	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	0.00	24.95	1.99	1.06	0.00	0.13	0.00	0.13	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	0.39	23.95	3.80	2.14	0.10	0.10	0.10	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	0.38	20.62	4.20	1.53	0.00	0.19	0.00	0.19	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	0.21	22.32	2.24	2.03	0.00	0.32	0.00	0.21	0.11	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	0.28	18.22	2.80	1.40	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	0.51	21.19	2.91	2.39	0.00	0.17	0.00	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	0.18	21.15	1.28	0.91	0.00	0.00	0.00	0.18	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	0.25	22.93	3.07	1.84	0.00	0.00	0.00	0.12	0.12	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	0.27	23.64	3.22	1.07	0.00	0.13	0.00	0.27	0.13	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	0.00	25.00	2.59	1.42	0.00	0.00	0.00	0.24	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	0.40	22.62	4.37	1.19	0.00	0.00	0.00	0.00	0.20	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	0.47	22.45	3.04	1.40	0.00	0.70	0.00	0.00	0.23	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	1.04	20.74	1.87	2.90	0.21	0.00	0.00	0.00	0.21	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	0.22	21.90	3.54	2.21	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	0.42	20.47	2.92	2.09	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	0.27	24.90	3.63	2.56	0.13	0.00	0.00	0.00	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	0.68	21.80	1.87	1.36	0.00	0.68	0.00	0.17	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	0.96	18.12	3.47	0.58	0.00	0.19	0.00	0.00	0.39	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	0.69	25.10	1.38	1.20	0.00	0.17	0.00	0.34	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	0.14	22.91	2.47	0.55	0.14	0.14	0.00	0.00	0.14	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	0.33	15.43	1.81	0.66	0.00	0.16	0.00	0.00	0.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	0.51	18.07	1.53	0.51	0.00	0.17	0.00	0.17	0.17	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	0.59	18.94	1.78	0.44	0.00	0.15	0.00	0.15	0.15	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	0.80	13.33	1.33	0.00	0.00	0.27	0.00	0.27	0.27	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	5.95	40.37	18.11	2.07	0.14	0.55	0.00	0.14	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	0.00	16.19	1.43	0.95	0.24	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	0.20	17.53	1.21	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	1.04	24.49	7.44	1.79	0.09	0.38	0.00	0.19	0.28	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	11.88	49.61	61.84	4.54	2.79	2.45	0.35	0.35	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	13.60	31.43	39.89	4.23	0.91	1.81	0.30	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	3.67	27.17	10.40	2.57	0.61	0.49	0.12	0.12	0.37	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	48.91	66.95	134.05	7.86	3.20	3.35	1.60	1.60	0.58	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	18.25	48.67	68.14	7.30	2.43	1.83	1.22	1.22	0.61	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	3.62	23.21	9.34	3.62	0.60	0.60	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	38.90	59.49	104.05	6.56	4.98	5.43	1.81	0.45	4.07	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	22.77	46.13	72.79	6.89	1.80	2.70	1.20	0.90	0.60	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	28.46	55.61	57.38	8.03	1.77	1.65	0.35	0.47	1.65	0.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	40.55	51.01	95.84	5.34	1.71	5.12	0.85	0.85	6.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	17.43	35.46	67.31	4.81	1.20	1.80	1.20	0.60	1.20	0.60
Schwann Cells, donor1	11498-119F4	3.39	85.38	12.79	1.50	0.00	1.50	0.00	0.56	0.56	0.00
Schwann Cells, donor2	11578-120F3	3.40	61.24	20.41	3.40	0.00	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	1.31	41.63	8.76	0.88	0.66	0.66	0.00	0.22	0.00	0.22
Sebocyte, donor1	11220-116B5	0.00	120.51	3.29	3.29	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor2	11301-117B5	0.46	54.69	2.76	1.38	0.00	0.00	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	0.82	49.47	7.63	2.27	0.00	0.21	0.00	0.62	0.00	0.00
Sertoli Cells, donor1	11255-116F4	11.60	82.83	164.00	18.22	3.31	8.28	4.97	3.31	1.66	1.66
Sertoli Cells, donor2	11333-117F1	11.30	33.89	81.91	16.95	8.47	8.47	2.82	0.00	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	19.00	89.65	94.22	4.57	2.55	5.28	1.85	0.35	1.14	0.44
Skeletal Muscle Cells, donor2	11358-117H8	15.18	67.22	74.45	1.45	1.45	2.89	3.61	0.72	0.72	0.72
Skeletal Muscle Cells, donor3	11430-118G8	0.84	45.98	4.18	2.51	0.00	0.00	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor4	11451-119A2	0.63	54.83	13.20	1.57	0.16	0.63	0.16	0.00	0.16	0.16
Skeletal Muscle Cells, donor5	11455-119A6	0.45	46.53	11.00	1.49	0.00	0.45	0.00	0.00	0.30	0.00
Skeletal Muscle Cells, donor6	11459-119B1	1.23	81.88	4.92	2.92	0.00	1.08	0.15	0.15	0.46	0.00
Skeletal Muscle Satellite Cells, donor1	11240-116D7	2.65	59.22	55.95	5.42	0.25	2.65	0.63	0.88	0.25	0.76
Skeletal Muscle Satellite Cells, donor2	11321-117D7	1.14	32.10	7.28	0.86	0.00	0.57	0.14	0.00	0.00	0.00
Skeletal Muscle Satellite Cells, donor3	11397-118D2	1.29	60.91	12.80	2.38	0.30	0.89	0.10	0.20	0.30	0.10
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	23.25	77.34	134.55	6.91	3.71	5.81	2.70	0.84	0.59	1.01
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	2.17	67.31	37.64	3.62	0.72	2.17	0.00	0.00	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	0.55	33.71	5.78	1.65	0.28	0.28	0.00	0.14	0.14	0.00
Skin - palm, donor1	10286-104F7	8.06	26.86	2.69	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	0.00	24.51	0.58	0.58	0.00	0.00	0.00	0.00	0.29	0.00
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	0.00	46.62	0.00	2.45	0.00	0.00	0.00	0.82	1.64	0.00
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	0.00	29.47	0.91	1.30	0.00	0.00	0.00	0.00	0.13	0.00
Small Airway Epithelial Cells, donor1	11256-116F5	0.83	112.74	40.59	13.48	0.00	1.53	0.70	0.56	0.14	0.00
Small Airway Epithelial Cells, donor2	11334-117F2	1.27	58.65	17.72	9.56	0.00	1.13	0.28	1.13	1.13	0.00
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	0.00	65.55	2.11	2.54	0.00	0.63	0.00	0.21	0.00	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	0.60	56.59	31.03	5.92	0.00	1.42	1.27	1.35	0.45	0.15
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	1.23	66.04	42.28	7.10	0.00	2.78	1.23	0.93	2.78	0.00
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	6.45	74.04	94.49	5.11	0.89	3.11	1.56	0.44	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	0.59	57.02	11.17	5.29	0.59	1.18	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	160.44	78.45	64.31	11.49	7.29	3.09	0.66	1.33	0.22	1.10
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.36	58.28	16.14	5.91	1.18	0.39	0.00	0.39	0.00	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	0.77	58.72	7.73	6.95	0.77	1.55	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	12.01	17.01	37.03	2.00	2.00	4.00	0.00	1.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	0.93	56.96	16.77	6.25	0.13	2.26	0.00	0.13	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	5.54	57.85	35.69	5.54	0.22	1.33	1.11	1.33	0.44	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	3.58	75.41	33.67	6.91	0.90	1.41	0.38	0.38	1.02	0.00
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	4.23	49.16	18.56	0.98	0.65	0.65	0.98	0.00	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	3.25	38.10	10.93	3.54	0.00	0.59	0.59	0.30	0.00	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	2.14	33.74	16.80	1.14	0.28	0.71	0.28	0.00	0.14	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	0.49	57.42	11.06	2.28	0.00	0.49	0.16	0.16	0.16	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	28.31	54.80	79.46	0.91	2.44	3.65	2.13	0.30	0.61	1.22
Smooth Muscle Cells - Carotid, donor1	11285-116I7	5.56	66.93	47.48	9.60	0.76	2.02	0.76	0.76	0.25	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	48.97	36.72	18.36	0.00	6.12	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.34	71.05	20.50	4.77	0.00	0.95	0.00	0.48	0.00	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	7.82	53.83	34.80	3.24	1.77	1.77	1.18	0.29	0.44	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	3.44	32.72	21.52	1.94	1.51	0.43	1.29	0.00	0.22	0.22
Smooth Muscle Cells - Colonic, donor3	11396-118D1	2.31	40.62	16.79	1.68	0.52	0.52	0.73	0.10	0.52	0.52
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.02	57.23	15.16	5.88	0.15	2.17	0.31	0.77	0.31	0.00
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	3.23	52.82	20.48	5.39	1.08	1.08	2.16	0.00	0.00	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	0.60	47.22	2.99	1.79	0.00	0.00	0.00	0.00	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.07	69.99	28.34	2.39	0.00	1.71	0.00	0.68	0.00	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	3.46	54.11	136.56	7.85	0.55	4.32	1.73	1.18	0.31	0.47
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1.71	58.37	18.82	7.04	0.40	1.11	0.70	0.30	0.40	0.00
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	1321.40	73.27	78.73	8.87	31.17	1.59	3.87	1.14	6.14	1.59
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.62	85.14	9.06	9.66	0.60	0.00	0.00	0.60	0.60	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	5.03	113.92	11.66	3.97	0.53	0.79	0.53	0.00	0.26	0.26
Smooth Muscle Cells - Prostate, donor1	11257-116F6	77.37	164.72	102.67	6.92	4.79	2.93	1.20	0.80	1.07	0.27
Smooth Muscle Cells - Prostate, donor2	11335-117F3	63.99	107.06	229.28	4.38	8.01	5.51	21.04	0.25	3.51	3.01
Smooth Muscle Cells - Prostate, donor3	11465-119B7	32.47	22.32	69.76	4.06	4.57	2.28	2.54	0.00	0.25	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	6.18	87.60	50.96	15.38	0.90	2.26	0.90	1.06	0.30	0.45
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	11.25	46.51	24.76	6.00	1.50	3.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	94.33	72.36	6.46	3.88	0.00	0.00	0.00	0.00	1.29	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	0.93	54.41	20.46	4.19	0.00	0.47	0.00	0.93	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	5.55	49.98	20.20	4.04	0.50	0.50	0.50	0.00	0.50	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	24.76	52.02	23.82	4.70	1.88	0.63	0.63	1.25	0.31	0.00
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	2.36	42.48	7.67	4.72	0.00	0.59	0.00	0.59	0.00	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	0.33	70.89	10.33	6.08	0.25	0.92	0.00	0.17	0.00	0.00
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	1.87	22.42	11.21	2.80	0.00	1.40	0.47	0.47	0.00	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	1.01	50.95	12.81	5.90	0.29	0.86	0.00	1.01	0.29	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	6.12	52.01	10.96	4.59	0.25	0.25	0.51	0.51	0.25	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	1.32	58.29	13.73	5.26	0.00	0.19	0.00	0.38	0.00	0.19
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	0.42	62.47	10.06	3.77	0.00	0.98	0.14	0.28	0.00	0.00
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	2.35	71.56	74.91	8.38	1.01	3.69	1.68	0.59	0.17	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.48	13.81	0.95	1.90	0.00	0.48	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	0.98	52.85	11.25	5.87	0.24	0.49	0.24	0.73	0.00	0.24
Smooth Muscle Cells - Uterine, donor1	11258-116F7	13.70	82.41	43.31	7.95	1.33	2.21	1.33	0.44	0.66	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	3.80	61.73	42.42	8.78	0.59	3.51	1.17	0.00	0.00	0.59
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	2.92	19.05	31.10	6.80	0.39	1.17	0.19	0.58	0.39	0.19
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	1.32	29.35	21.69	2.12	0.26	2.12	0.26	0.00	1.06	0.00
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	24.55	51.33	29.76	7.44	1.86	1.49	1.12	0.74	1.12	0.00
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	12.22	42.76	22.64	3.95	0.72	0.36	0.72	0.72	0.00	0.00
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	1.70	21.29	5.39	1.14	0.28	0.00	0.00	0.00	0.85	0.00
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	1.18	45.69	18.91	5.12	0.39	1.58	0.00	0.00	0.00	0.00
Smooth muscle cells - airway, control, donor1	11966-126D4	14.98	31.49	41.14	4.83	1.52	2.29	1.02	0.25	1.02	0.25
Smooth muscle cells - airway, control, donor2	11967-126D5	17.17	19.97	25.16	3.59	2.40	1.60	0.00	0.00	0.00	0.40
Smooth muscle cells - airway, control, donor3	11968-126D6	7.94	17.56	22.99	4.60	0.42	0.84	0.00	0.00	1.25	0.00
Smooth muscle cells - airway, control, donor4	11969-126D7	16.96	25.21	54.09	6.88	1.83	3.21	0.46	0.00	0.46	1.38
Synoviocyte, donor1	11291-117A4	3.53	41.58	75.74	12.46	0.84	4.88	0.34	0.34	0.34	0.17
Synoviocyte, donor2	11368-117I9	77.11	27.66	70.40	8.21	5.87	2.68	4.69	0.84	1.51	1.68
Synoviocyte, donor3	11440-118H9	25.25	21.45	38.65	4.24	2.01	0.89	1.12	0.22	0.89	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	0.00	98.62	15.72	1.79	0.36	0.00	0.00	0.36	0.00	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	0.00	79.28	83.25	1.98	0.00	3.96	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	0.46	53.26	32.65	1.39	0.00	0.93	0.23	0.23	0.00	0.00
Tracheal Epithelial Cells, donor1	11292-117A5	0.36	56.56	22.15	8.46	0.00	1.51	0.14	1.08	0.22	0.00
Tracheal Epithelial Cells, donor2	11369-118A1	0.77	38.27	7.34	1.55	0.00	0.39	0.39	0.00	1.16	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	1.15	56.69	9.74	1.72	0.00	0.00	0.00	0.57	1.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	110.35	31.62	34.20	11.20	1.85	1.48	8.73	0.49	1.35	0.49
Urethra, donor2	10319-105A4	12.59	26.98	1.80	1.80	0.00	1.80	1.80	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	0.80	67.74	7.17	6.64	0.00	0.53	0.00	0.27	0.00	0.00
Urothelial Cells, donor2	11600-120H7	0.00	39.66	4.41	2.40	0.00	0.40	0.00	0.00	0.80	0.00
Urothelial Cells, donor3	11681-122H7	0.00	28.19	2.29	4.81	0.00	0.69	0.00	0.23	0.23	0.00
Urothelial cells, donor0	11216-116B1	0.00	47.25	4.90	8.25	0.00	0.67	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation1	12179-129A1	93.43	102.33	8.01	8.90	0.89	0.00	0.00	1.78	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	90.07	107.22	8.58	5.72	2.86	0.00	0.00	2.86	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	54.08	45.86	8.21	2.05	0.00	0.68	1.37	0.68	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	74.03	73.00	11.36	7.92	1.72	1.38	0.00	2.07	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	100.52	74.95	18.01	12.20	2.91	1.16	0.00	1.16	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	68.72	101.00	8.33	7.29	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	78.01	89.94	4.59	7.34	2.75	0.00	0.00	1.84	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	52.95	33.78	5.48	2.74	0.91	0.91	0.00	0.00	0.91	0.00
Wilms' tumor cell line:G-401	10809-111A8	0.00	45.40	1.73	0.25	0.12	0.00	0.25	0.00	0.12	0.00
Wilms' tumor cell line:HFWT	10597-108E3	48.40	65.12	22.00	0.88	4.40	1.76	0.88	0.00	0.00	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	1.12	34.64	3.07	0.28	0.28	0.28	0.00	0.28	0.56	0.00
achilles tendon, donor2	10292-104G4	741.88	33.06	12.40	4.13	6.20	0.00	0.00	0.00	8.27	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	5.35	89.23	17.59	2.55	0.76	0.76	0.00	0.00	0.25	0.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	0.00	72.21	6.27	1.63	0.00	1.16	0.00	0.00	0.00	0.00
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	0.12	42.97	1.07	1.42	0.12	0.47	0.00	0.24	0.12	0.00
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	0.00	81.09	0.27	0.27	0.00	0.00	0.00	0.00	0.27	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	9.28	72.80	22.21	3.94	1.41	0.84	0.56	0.00	0.00	0.56
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	0.42	31.30	5.50	8.04	0.21	0.21	0.00	0.21	0.00	0.21
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	10.62	63.97	248.80	22.59	1.91	7.62	5.17	1.91	0.82	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	0.88	55.96	3.53	2.20	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	1.63	51.45	10.21	8.98	0.82	0.82	0.41	0.41	0.41	0.00
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	1.55	45.82	0.39	1.55	0.00	0.00	0.00	0.00	0.39	0.00
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	0.00	92.55	1.29	2.02	0.00	0.37	0.00	0.18	0.55	0.00
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	0.00	58.51	3.90	0.00	3.90	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	2.09	46.71	12.32	10.69	1.16	0.46	0.70	0.23	0.00	0.23
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	12.69	91.39	10.10	5.95	1.81	1.04	0.52	1.04	0.78	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	7.89	109.01	4.97	3.21	2.05	0.58	0.00	0.00	0.00	0.58
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	11.62	81.80	39.50	9.76	0.00	3.72	0.00	1.39	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	0.41	59.63	1.65	3.70	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	2.15	38.06	0.92	0.31	0.00	0.31	0.31	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	6.83	71.69	8.53	2.13	0.43	0.85	0.85	0.43	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	4.85	65.21	3.34	3.64	0.00	0.61	0.00	0.30	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	5.54	78.23	10.11	2.41	0.72	0.24	0.48	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.45	85.31	5.35	6.90	0.22	0.00	0.00	1.34	0.22	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	1.00	64.04	6.34	4.34	0.33	2.00	0.33	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	74.33	139.37	52.03	3.72	9.29	1.86	1.86	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	10.17	97.93	72.32	24.86	2.64	3.39	1.13	1.13	0.75	2.26
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	0.00	32.71	1.74	0.87	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	200.57	86.23	29.99	9.37	9.37	3.75	1.87	0.00	0.00	3.75
adenocarcinoma cell line:IM95m	10796-110I4	0.47	46.63	4.47	4.47	0.00	0.24	0.00	0.94	0.00	0.00
adipose tissue, adult, pool1	10010-101C1	132.94	33.35	12.41	6.36	2.48	0.62	0.16	1.09	0.31	0.31
adipose, donor1	10184-103D4	0.00	78.58	5.86	0.00	0.59	0.59	0.00	0.00	1.17	0.00
adipose, donor2	10185-103D5	0.41	26.76	1.62	0.00	0.00	0.41	0.00	0.00	0.81	0.00
adipose, donor3	10186-103D6	2.18	36.49	7.08	0.00	0.00	0.54	0.00	0.27	0.82	0.00
adipose, donor4	10187-103D7	0.00	53.74	11.27	1.73	0.87	0.00	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	0.32	118.05	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adrenal gland, adult, pool1	10081-102A9	7.28	36.38	3.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	363.00	154.22	15.21	1.47	10.01	0.93	0.67	0.00	1.20	0.93
alveolar cell carcinoma cell line:SW 1573	10708-109H6	3.57	43.95	2.86	1.07	0.71	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor1	12235-129G3	1.62	20.87	0.23	0.23	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor2	12236-129G4	6.09	27.05	1.01	0.68	0.00	0.00	0.00	0.00	0.00	0.00
amniotic membrane cells, donor3	12237-129G5	0.29	18.85	0.29	0.29	0.00	0.00	0.00	0.00	0.00	0.00
amygdala - adult, donor10196	10167-103B5	67.59	62.85	2.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	15.41	53.33	3.04	2.03	0.20	0.20	0.00	0.20	0.00	0.00
amygdala, newborn, donor10223	10360-105E9	24.53	48.74	6.78	0.97	0.65	0.65	0.00	0.00	0.00	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	16.93	75.12	99.83	32.47	1.27	8.91	1.53	2.04	0.13	0.25
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	6.84	55.16	6.18	0.88	0.88	0.22	0.22	0.22	0.22	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	1.00	71.82	8.02	1.34	0.00	0.33	0.67	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	23.54	20.01	4.12	2.16	0.59	0.20	0.00	0.00	0.00	0.00
appendix, adult	10189-103D9	122.65	39.98	2.72	2.33	1.55	0.39	0.00	0.00	0.39	0.00
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	0.00	37.14	0.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
artery, adult	10190-103E1	51.63	27.17	6.79	1.36	1.36	1.36	1.36	0.00	0.00	0.00
astrocytoma cell line:TM-31	10425-106D2	15.65	66.35	14.05	7.10	2.03	1.59	0.29	0.43	0.14	0.14
b cell line:RPMI1788	10427-106D4	131.90	128.03	52.05	6.54	6.84	2.97	2.08	0.30	0.45	1.04
basal cell carcinoma cell line:TE 354.T	10702-109G9	4.44	73.52	75.19	21.92	0.28	4.44	1.11	1.11	1.11	0.83
bile duct carcinoma cell line:HuCCT1	10432-106D9	1.98	140.71	21.14	23.52	0.10	3.08	0.00	2.48	0.30	0.00
bile duct carcinoma cell line:TFK-1	10496-107C1	5.36	122.52	12.22	2.51	0.33	0.84	0.00	0.00	0.00	0.17
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	38.03	85.56	34.67	10.63	5.59	1.68	1.12	0.56	0.00	1.12
bladder, adult, pool1	10011-101C2	17.06	26.94	7.71	2.28	0.54	0.54	0.11	0.22	0.11	0.11
blood, adult, pool1	10053-101G8	130.66	39.86	0.00	8.86	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	0.00	22.27	2.57	1.71	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	40.49	33.07	8.77	4.72	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, donor1	10084-102B3	2.05	48.18	2.05	1.03	0.00	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	19.38	62.81	3.34	1.22	0.45	0.33	0.00	0.11	0.33	0.11
brain, fetal, pool1	10085-102B4	2.67	66.78	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	1.65	94.15	29.73	2.64	0.00	1.65	0.99	0.66	0.66	0.00
breast carcinoma cell line:MDA-MB-453	10419-106C5	0.12	66.53	0.50	0.00	0.12	0.00	0.00	0.00	0.12	0.00
breast, adult, donor1	10080-102A8	5.05	11.36	4.42	2.53	1.89	0.00	0.00	0.63	1.26	0.00
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	2.54	115.48	13.47	6.61	0.25	1.14	0.89	0.25	0.51	0.00
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	39.58	56.90	5.26	0.93	0.00	0.62	0.62	0.00	0.31	0.62
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	0.23	53.18	0.92	1.38	0.23	0.00	0.00	0.00	0.00	0.00
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	4.36	51.32	3.39	0.00	0.24	0.00	0.24	0.00	0.00	0.00
carcinoid cell line:NCI-H1770	10703-109H1	0.00	45.14	1.88	0.94	0.00	0.00	0.00	0.00	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	2.52	74.93	20.13	2.30	0.22	1.42	0.66	0.00	0.11	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	0.00	18.38	0.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
carcinosarcoma cell line:JHUCS-1	10642-109A3	7.19	88.37	34.34	2.40	0.53	1.33	2.13	0.27	0.80	0.27
caudate nucleus - adult, donor10196	10177-103C6	93.26	56.41	6.91	4.61	0.00	0.00	1.15	1.15	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	41.83	61.41	3.01	2.01	0.84	0.17	0.00	0.33	0.00	0.17
caudate nucleus, adult, donor10258	10379-105H1	11.46	51.96	0.00	0.76	0.00	0.00	0.76	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	31.86	39.92	4.76	1.10	1.10	0.00	0.00	0.00	0.00	0.00
cerebellum - adult, donor10196	10173-103C2	26.22	37.87	5.83	2.91	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	3.20	39.50	2.35	0.43	0.00	0.00	0.00	0.00	0.21	0.21
cerebellum, adult, pool1	10083-102B2	8.28	29.67	0.34	0.00	0.00	0.00	0.34	0.00	0.69	0.00
cerebellum, newborn, donor10223	10357-105E6	4.98	34.87	0.83	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	7.06	46.65	1.51	0.76	0.25	0.25	0.00	0.00	0.00	0.00
cerebrospinal fluid, donor2	10294-104G6	72.36	25.58	3.65	2.19	0.73	0.00	0.73	0.73	0.73	0.73
cervical cancer cell line:D98-AH2	10552-107I3	24.44	165.35	489.87	3.45	2.44	6.04	25.74	0.29	1.29	1.73
cervical cancer cell line:ME-180	10553-107I4	8.78	159.42	137.21	10.77	1.33	6.13	4.31	2.15	0.17	0.50
cervix, adult, pool1	10013-101C4	14.17	27.19	4.20	2.94	0.52	0.52	0.10	0.31	0.31	0.10
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	2.93	58.80	42.22	4.04	0.00	2.51	0.42	0.28	0.28	0.14
chondrosarcoma cell line:SW 1353	10700-109G7	1.31	20.90	5.23	3.92	0.00	1.31	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	0.12	83.26	12.68	0.87	0.00	0.12	0.12	0.12	0.50	0.00
choriocarcinoma cell line:SCH	10785-110H2	1.36	126.54	80.95	0.25	0.37	0.25	4.93	0.12	0.49	0.49
choriocarcinoma cell line:T3M-3	10618-108G6	0.24	62.14	3.08	0.71	0.00	0.24	0.24	0.00	0.24	0.00
chorionic membrane cells, donor1	12238-129G6	11.11	14.25	1.99	2.56	0.85	0.57	0.00	0.28	0.00	0.00
chorionic membrane cells, donor2	12239-129G7	7.16	49.62	9.84	4.47	0.10	0.99	0.20	0.30	0.30	0.00
chorionic membrane cells, donor3	12240-129G8	43.96	20.88	12.64	3.85	0.00	2.20	2.20	1.65	0.00	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	0.00	24.24	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	0.19	25.93	0.58	1.54	0.00	0.19	0.00	0.00	0.38	0.00
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	3.80	38.01	43.72	13.52	0.00	2.96	1.90	0.63	0.00	1.06
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	1.54	98.10	27.99	2.82	0.00	0.51	1.28	0.51	0.26	2.82
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	1.94	99.65	32.17	3.14	0.48	1.45	1.94	0.00	0.00	1.69
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	4.07	98.55	47.64	4.48	0.20	1.02	1.83	0.61	0.20	2.85
chronic myelogenous leukemia cell line:K562	10454-106G4	0.00	97.17	15.02	4.12	0.00	0.59	0.00	0.00	0.59	0.59
chronic myelogenous leukemia cell line:KU812	10409-106B4	4.95	102.95	47.17	11.73	0.78	2.61	1.04	0.78	0.00	1.30
clear cell carcinoma cell line:JHOC-5	10638-108I8	0.23	35.66	0.69	1.14	0.00	0.23	0.00	0.00	0.69	0.00
clear cell carcinoma cell line:TEN	10636-108I6	2.43	72.01	5.38	2.78	0.00	0.35	0.17	0.17	0.17	0.17
colon carcinoma cell line:CACO-2	10513-107D9	0.37	51.98	2.01	1.28	0.18	0.37	0.18	0.00	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	0.38	87.04	21.66	3.04	0.00	1.52	0.00	0.00	0.38	0.00
colon, adult, donor1	10082-102B1	13.09	26.18	1.19	0.00	1.19	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	22.09	25.03	5.64	1.53	0.94	0.35	0.24	0.12	0.47	0.12
colon, fetal, donor1	10070-101I7	12.98	10.51	2.47	0.00	0.62	0.00	0.62	0.00	0.62	0.00
common myeloid progenitor CMP, donor1	12130-128D6	0.00	41.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	2344.35	422.38	59.49	2.55	41.64	2.55	2.12	0.00	1.27	5.52
cord blood derived cell line:COBL-a 24h infection	10453-106G3	1290.62	352.43	44.07	1.06	26.87	2.26	3.32	0.30	1.96	3.02
cord blood derived cell line:COBL-a untreated	10449-106F8	1224.68	367.76	42.87	1.97	23.69	2.40	1.69	0.28	0.85	2.68
corpus callosum, adult, pool1	10042-101F6	22.89	56.17	6.52	4.31	0.33	0.66	0.33	0.11	0.11	0.00
cruciate ligament, donor2	10295-104G7	82.67	28.37	13.78	4.05	3.24	1.62	0.00	0.00	0.00	0.00
diaphragm, fetal, donor1	10069-101I6	20.06	21.67	9.63	2.41	0.00	0.80	0.80	0.00	0.00	0.00
diencephalon, adult	10193-103E4	10.56	39.84	0.48	0.72	0.00	0.48	0.00	0.00	0.24	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	1.38	37.89	8.73	0.92	0.46	0.46	0.46	0.00	0.46	0.00
ductal cell carcinoma cell line:KLM-1	10438-106E6	139.50	245.16	80.52	4.62	6.92	4.10	0.51	0.77	0.26	0.00
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	343.27	153.58	245.54	1.44	14.44	7.22	75.83	0.00	2.41	5.06
ductus deferens, adult	10196-103E7	6.48	26.91	1.99	1.00	0.50	0.50	0.00	0.00	1.00	0.00
duodenum, fetal, donor1, tech_rep1	10071-101I8	17.28	20.16	8.64	4.32	1.44	1.44	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	45.61	28.69	7.36	2.21	2.94	0.74	1.47	0.74	1.47	0.00
dura mater, adult, donor1	10041-101F5	151.80	65.33	13.46	3.39	3.22	0.33	0.58	0.08	0.50	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	152.79	133.69	52.85	7.55	4.66	7.55	0.00	0.67	2.00	0.67
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	0.00	76.23	1.58	0.14	0.00	0.00	0.00	0.00	0.43	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	35.15	107.91	28.98	2.47	0.62	4.32	0.62	0.00	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	85.06	91.42	28.45	4.24	0.91	3.03	0.30	1.51	0.91	0.00
embryonic pancreas cell line:1C3IKEI	10606-108F3	32.73	138.01	35.81	5.25	0.31	5.56	0.93	0.93	0.31	0.00
embryonic pancreas cell line:2C6	10603-108E9	49.91	111.64	23.64	3.94	1.31	1.31	1.31	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	64.02	117.65	37.21	0.00	6.70	3.02	4.02	0.00	0.67	0.34
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	9.79	80.65	39.51	10.15	1.09	5.44	0.18	1.45	0.18	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	2.09	49.69	0.64	0.16	0.00	0.16	0.00	0.00	0.48	0.00
epidermoid carcinoma cell line:A431	10426-106D3	67.03	120.16	70.14	11.67	2.67	4.00	0.44	1.11	0.22	0.33
epidermoid carcinoma cell line:Ca Ski	10431-106D8	6.05	118.34	26.07	2.64	0.44	0.44	0.22	0.00	0.00	0.11
epididymis, adult	10197-103E8	18.00	43.75	5.44	2.72	0.84	0.63	0.00	0.21	0.84	0.00
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	5.85	21.47	10.64	0.89	0.35	0.35	0.18	0.00	0.18	0.53
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	12.98	86.91	55.05	0.00	0.79	2.36	2.75	0.00	0.00	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	1.70	83.48	17.30	5.24	0.26	0.66	0.00	0.13	0.13	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	1.67	88.48	36.42	6.79	0.20	1.67	0.89	0.20	0.39	0.10
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	2.58	88.17	13.33	3.02	0.11	1.01	0.34	0.11	0.22	0.00
esophagus, adult, pool1	10015-101C6	28.67	29.84	5.63	2.97	0.74	0.64	0.53	0.11	0.11	0.00
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	65.25	146.40	194.49	0.25	15.78	4.76	9.89	0.25	0.25	2.63
eye - muscle inferior rectus, donor1	10272-104E2	99.00	26.56	16.90	4.83	0.00	2.41	0.00	0.00	0.00	0.00
eye - muscle lateral, donor2	10298-104H1	284.07	27.35	10.52	0.00	2.10	0.00	2.10	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	61.02	16.37	4.46	1.49	0.00	2.98	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	158.22	18.34	8.03	3.44	0.00	3.44	1.15	1.15	0.00	0.00
eye - vitreous humor, donor1	10268-104D7	64.13	20.40	11.66	1.46	0.00	0.00	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	10.42	25.68	6.61	0.00	0.00	0.25	1.02	0.51	0.25	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	7.44	117.84	50.91	11.54	1.41	5.26	0.64	1.28	0.26	0.13
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	0.47	32.29	1.19	0.24	0.00	0.47	0.00	0.00	0.00	0.00
frontal lobe, adult, pool1	10040-101F4	8.07	93.92	1.13	1.03	0.00	0.09	0.00	0.00	0.09	0.00
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	117.70	64.55	20.72	1.80	1.80	0.00	1.50	0.30	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	1.65	68.76	2.56	0.91	0.00	0.27	0.00	0.09	0.09	0.00
gall bladder, adult	10198-103E9	24.63	33.08	5.07	1.69	1.21	0.24	0.24	0.48	0.00	0.24
gamma delta positive T cells, donor1	11937-126A2	0.00	29.53	0.00	0.54	0.00	0.00	0.00	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	21.66	36.98	6.72	1.12	0.75	0.00	0.75	0.00	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	279.02	120.82	116.80	7.18	8.03	3.59	3.38	0.00	2.32	0.63
gastric adenocarcinoma cell line:MKN45	10612-108F9	30.37	168.66	80.07	1.55	2.32	1.16	2.71	0.00	0.39	0.97
gastric cancer cell line:AZ521	10549-107H9	0.82	189.86	1.48	1.64	0.16	1.97	0.16	0.49	0.16	0.00
gastric cancer cell line:GSS	10560-108A2	0.00	47.59	0.00	1.83	0.00	0.00	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	8.45	79.50	137.30	4.34	0.69	10.74	7.54	0.91	1.14	0.00
giant cell carcinoma cell line:LU65	10487-107B1	2.18	115.54	32.01	20.77	0.00	0.57	0.00	2.87	0.69	0.00
giant cell carcinoma cell line:Lu99B	10433-106E1	3.36	56.12	69.98	3.22	0.98	5.88	1.96	0.56	0.00	0.28
glassy cell carcinoma cell line:HOKUG	10688-109F4	53.62	125.71	62.35	12.47	2.00	3.24	4.24	1.25	0.00	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	2.64	29.13	5.28	1.58	0.21	0.42	0.11	0.00	0.11	0.00
glioblastoma cell line:A172, tech_rep2	10444-106F3	1.83	28.09	3.23	1.40	0.14	0.28	0.00	0.14	0.00	0.00
glioblastoma cell line:T98G	10485-107A8	30.02	51.21	62.47	2.98	2.43	2.43	1.21	0.22	0.11	0.55
glioma cell line:GI-1	10413-106B8	8.79	86.98	94.60	2.64	0.88	8.79	2.34	0.88	0.29	0.00
globus pallidus - adult, donor10196	10175-103C4	74.35	24.05	2.92	1.46	1.46	0.73	1.46	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	24.17	47.84	6.83	3.42	1.22	0.24	0.49	0.24	0.00	0.00
globus pallidus, adult, donor10258	10367-105F7	16.43	41.08	2.74	1.37	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	73.54	31.98	5.33	3.20	0.00	0.53	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	0.00	58.73	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	76.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	0.00	83.63	5.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	2.88	37.76	22.40	4.48	0.32	0.96	0.00	0.32	0.00	0.00
hIPS +CCl2, biol_rep1	14383-156B9	1.38	81.26	27.55	1.38	0.00	0.92	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep2	14384-156C1	2.74	76.82	15.55	1.83	0.00	0.91	0.00	0.91	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	0.64	56.68	14.17	0.64	0.00	0.00	0.00	0.00	1.29	0.00
hIPS, biol_rep1	14380-156B6	4.31	79.05	1.44	2.87	0.00	0.00	0.00	0.00	0.00	0.00
hIPS, biol_rep2	14381-156B7	0.00	54.87	12.35	2.06	0.00	1.37	0.00	0.00	0.00	0.00
hIPS, biol_rep3	14382-156B8	23.17	45.24	6.62	1.10	0.00	0.00	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	86.49	84.48	27.30	2.30	4.31	3.45	0.57	0.29	0.57	0.29
heart - mitral valve, adult	10205-103F7	123.77	24.22	23.32	3.89	2.69	0.60	2.39	0.30	0.30	0.00
heart - pulmonic valve, adult	10206-103F8	50.99	17.78	7.32	2.61	0.26	1.57	0.78	0.26	0.26	0.00
heart - tricuspid valve, adult	10207-103F9	266.45	39.97	26.64	5.00	4.16	1.67	1.67	0.00	0.00	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	29.59	51.01	17.34	1.22	0.20	0.41	0.82	0.00	0.82	0.41
heart, adult, diseased, donor1	10051-101G6	66.43	37.90	30.23	0.85	1.70	0.85	2.55	0.00	0.43	0.43
heart, adult, pool1	10016-101C7	51.28	24.38	15.64	1.38	1.61	1.15	1.38	0.23	0.23	0.00
heart, fetal, pool1	10046-101G1	71.98	33.17	59.86	4.83	1.85	3.18	4.31	1.03	0.10	0.21
hepatic mesenchymal tumor cell line:LI90	10778-110G4	1.54	26.84	16.04	6.79	0.00	1.54	0.00	0.00	0.00	0.31
hepatoblastoma cell line:HuH-6	10633-108I3	0.00	54.70	3.57	1.19	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	0.22	57.24	4.42	2.65	0.00	0.33	0.00	0.11	0.55	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	0.49	61.17	5.95	2.31	0.12	0.49	0.00	0.00	0.24	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	0.10	61.64	5.76	2.53	0.10	0.61	0.10	0.20	0.10	0.00
hepatoma cell line:Li-7	10484-107A7	31.81	119.89	115.00	2.67	3.00	5.78	1.45	0.33	0.67	1.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	42.41	206.03	40.50	3.12	2.41	4.22	0.80	0.00	0.40	0.20
hippocampus - adult, donor10196	10169-103B7	63.40	60.56	3.79	2.84	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	17.96	47.56	2.65	0.61	0.41	0.20	0.00	0.20	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	10.46	40.33	1.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	51.11	31.02	2.47	0.70	0.00	0.70	0.35	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	1.83	95.82	50.66	3.66	0.00	5.49	1.83	1.22	1.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	0.98	61.46	23.56	2.16	0.00	2.36	0.39	0.20	0.98	0.20
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	2.03	59.16	25.39	2.03	0.25	2.79	0.25	0.00	0.76	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	0.00	31.58	5.07	0.56	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	0.00	34.34	3.36	0.26	0.00	0.52	0.00	0.00	1.03	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	0.38	42.90	4.18	0.00	0.00	0.76	0.00	0.00	0.38	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	3.21	57.51	11.09	0.00	1.46	1.17	0.00	0.00	0.58	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	1.29	53.86	6.25	0.65	0.22	1.51	0.22	0.00	0.65	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	4.59	56.72	11.68	0.00	0.00	0.83	0.42	0.00	0.83	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	0.95	58.01	4.03	0.00	0.24	0.00	0.47	0.00	0.24	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	1.77	47.09	3.05	0.16	0.16	0.80	0.16	0.16	1.29	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	0.67	53.19	4.04	0.00	0.67	0.00	0.00	0.00	0.67	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	0.63	47.10	10.64	2.97	0.16	0.31	0.00	0.00	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	0.49	39.30	13.76	0.49	0.98	1.97	0.00	0.00	1.97	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	1.75	66.33	27.93	4.36	0.00	3.49	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	0.38	42.57	1.72	0.19	0.00	0.19	0.19	0.00	1.15	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	1.74	34.89	2.62	0.44	0.00	0.00	0.00	0.00	0.44	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	0.50	36.48	1.50	0.50	0.00	0.00	0.00	0.00	0.50	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	0.19	39.19	1.88	0.00	0.19	0.19	0.00	0.00	1.51	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	0.45	40.92	2.73	0.00	0.00	0.45	0.00	0.00	0.91	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	0.00	40.09	2.19	0.00	0.00	1.88	0.00	0.00	0.63	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	0.98	39.52	4.74	0.16	0.33	0.49	0.16	0.00	0.98	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	0.87	50.80	5.23	0.29	0.00	0.00	0.00	0.00	0.87	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	0.00	46.03	5.08	0.00	0.00	0.30	0.60	0.00	0.30	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	0.55	58.38	27.53	1.85	0.37	2.77	0.18	0.18	0.55	0.18
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	1.71	64.19	19.97	2.57	0.00	3.14	0.29	0.29	1.14	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	1.22	83.30	40.01	4.08	2.04	2.04	0.82	0.41	0.41	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	2.46	48.59	6.34	0.35	0.00	0.00	0.70	0.00	1.76	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	1.90	51.95	9.19	1.27	0.63	0.95	0.32	0.32	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	3.33	43.88	7.57	0.61	0.30	0.61	0.30	0.30	0.91	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	1.55	54.30	8.27	1.03	0.00	0.52	0.00	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	2.66	54.46	4.65	0.00	0.00	0.66	0.66	0.00	0.66	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	3.33	47.46	7.70	0.26	0.26	1.28	0.00	0.26	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	6.14	50.36	6.65	0.00	1.02	0.51	0.00	0.00	0.77	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	3.79	51.49	4.54	0.76	0.76	0.76	0.00	0.00	3.03	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	5.04	43.35	7.39	1.01	0.00	0.00	0.00	0.00	0.67	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	0.72	67.14	21.25	3.14	0.24	1.21	0.00	0.97	0.72	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	0.89	55.26	24.51	1.34	0.00	2.23	0.45	0.45	3.12	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	0.00	60.00	15.12	0.49	0.00	2.44	0.00	0.49	0.98	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	2.44	52.57	6.11	1.22	0.00	0.00	0.00	0.00	2.44	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	0.00	221.22	45.55	0.00	0.00	3.25	0.00	0.00	6.51	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	0.33	64.20	6.29	0.66	0.33	0.33	0.00	0.00	1.32	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	1.64	61.84	2.74	1.09	0.00	1.09	1.09	0.00	1.09	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	1.81	51.03	6.88	0.36	0.00	0.00	0.00	0.00	1.81	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	3.20	45.20	5.34	0.00	1.42	1.07	0.36	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	1.19	42.96	4.77	0.00	1.19	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	1.49	74.48	6.23	0.81	0.41	1.08	0.14	0.14	1.08	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	0.00	44.45	2.16	0.00	0.00	0.27	0.27	0.00	1.62	0.00
immature langerhans cells, donor1	11904-125F5	3.39	85.96	3.63	3.15	0.24	0.24	0.24	0.00	0.00	0.00
immature langerhans cells, donor2	11905-125F6	1.58	50.70	0.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	12.78	105.99	1.51	0.57	0.76	0.00	0.00	0.09	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	1.95	27.64	2.60	0.98	0.00	0.00	0.33	0.00	0.00	0.00
kidney, adult, pool1	10017-101C8	57.47	49.26	9.91	2.60	1.70	0.70	0.40	0.50	0.20	0.30
kidney, fetal, pool1	10045-101F9	31.19	44.85	10.26	3.47	1.27	0.64	0.42	0.21	0.07	0.00
large cell lung carcinoma cell line:IA-LM	10509-107D5	82.23	143.44	32.52	3.27	5.54	0.28	1.56	0.14	0.14	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	68.57	91.93	102.71	4.15	3.46	6.77	9.82	0.69	2.90	0.14
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	10.46	84.59	51.20	1.47	0.73	2.20	0.00	0.37	0.18	0.37
left atrium, adult, donor1	10079-102A7	51.22	13.62	8.17	0.54	1.09	0.00	1.09	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	60.68	21.74	9.61	0.51	2.53	0.51	0.51	1.01	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	2.46	41.32	1.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leiomyoma cell line:10964C	10569-108B2	5.39	33.41	9.70	2.87	1.80	0.36	0.36	0.00	0.36	0.00
leiomyoma cell line:15242A	10570-108B3	7.61	28.80	3.26	1.09	0.00	0.00	0.00	0.00	0.54	0.00
leiomyoma cell line:15425	10571-108B4	0.49	49.78	4.86	1.46	0.24	0.24	0.00	0.24	0.97	0.00
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	50.79	44.45	19.05	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	1.05	12.55	2.09	0.00	0.00	0.00	0.00	0.00	0.00	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	186.30	146.75	267.52	5.31	32.35	5.67	23.38	0.94	1.77	48.64
liposarcoma cell line:KMLS-1	10782-110G8	1.41	37.33	6.72	1.41	0.31	0.47	0.16	0.16	0.00	0.00
liposarcoma cell line:SW 872	10726-110A6	35.82	47.88	30.58	1.34	2.92	0.49	0.61	0.12	0.24	0.12
liver, adult, pool1	10018-101C9	14.10	36.79	10.05	4.54	0.49	0.81	0.32	0.65	0.16	0.00
liver, fetal, pool1	10086-102B5	2.82	12.23	3.76	1.88	0.00	0.94	0.00	0.00	0.00	0.00
locus coeruleus - adult, donor10196	10182-103D2	50.75	41.56	3.79	0.87	0.87	0.44	0.58	0.29	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	16.79	45.21	4.61	1.85	0.18	0.00	1.66	0.00	0.37	0.37
locus coeruleus, adult, donor10258	10375-105G6	12.70	37.81	3.39	1.13	0.00	0.00	1.97	0.28	0.00	0.00
locus coeruleus, newborn, donor10223	10362-105F2	103.89	50.05	10.94	4.63	1.26	0.42	0.84	0.42	0.42	0.00
lung adenocarcinoma cell line:A549	10499-107C4	0.97	206.62	55.36	3.04	0.14	4.84	1.66	0.42	0.14	0.00
lung adenocarcinoma cell line:PC-14	10408-106B3	0.00	7.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	45.08	51.94	29.53	1.19	7.38	0.00	6.85	0.00	0.13	0.40
lung, adult, pool1	10019-101D1	243.22	49.50	28.00	6.62	2.48	1.77	2.60	0.71	1.42	0.35
lung, fetal, donor1	10068-101I5	252.30	70.21	28.83	18.84	4.28	1.43	0.00	3.42	0.57	0.29
lung, right lower lobe, adult, donor1	10075-102A3	180.08	39.86	18.79	4.12	1.83	0.92	0.46	0.46	2.75	0.92
lymph node, adult, donor1	10077-102A5	17.99	37.87	6.63	5.21	2.37	0.47	0.95	0.47	0.47	0.00
lymphangiectasia cell line:DS-1	10727-110A7	4.16	65.31	0.44	0.66	0.44	0.00	0.00	0.00	0.00	0.00
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	0.30	65.35	0.91	0.45	0.00	0.15	0.00	0.00	0.15	0.00
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	368.68	107.89	241.26	11.89	11.04	5.10	5.95	0.85	0.00	0.85
mature adipocyte, donor1	12231-129F8	22.64	15.98	1.78	0.44	0.44	0.00	0.00	0.00	0.00	0.00
mature adipocyte, donor2	12232-129F9	97.95	17.02	11.41	1.66	0.62	0.21	0.62	0.42	0.00	0.21
mature adipocyte, donor3	12233-129G1	55.95	22.05	6.87	0.71	0.95	0.47	0.71	0.00	0.00	0.00
mature adipocyte, donor4	12234-129G2	23.43	20.79	3.42	0.26	1.05	1.05	0.00	0.00	0.26	0.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	0.71	149.39	11.91	1.91	0.00	2.62	0.00	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	45.12	67.68	4.51	0.00	0.00	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	14.34	61.06	3.13	1.84	0.37	0.18	0.18	0.18	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	5.72	50.83	0.00	0.32	0.00	0.00	0.00	0.32	0.64	0.00
medial frontal gyrus, newborn, donor10223	10352-105E1	53.74	84.02	12.37	2.56	2.99	0.85	0.43	0.00	0.00	0.00
medial temporal gyrus - adult, donor10196	10183-103D3	46.24	64.29	3.04	1.18	1.01	0.17	0.51	0.00	0.84	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	12.31	61.33	2.76	1.06	0.00	0.21	0.42	0.21	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	17.34	50.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	71.77	71.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	19.38	60.66	3.95	0.72	0.72	0.00	0.00	0.00	0.36	0.00
medulla oblongata - adult, donor10196	10174-103C3	57.76	28.56	1.95	0.00	0.65	0.65	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	18.11	36.84	4.80	3.10	0.77	0.15	0.93	0.00	0.00	0.00
medulla oblongata, adult, pool1	10038-101F2	114.60	77.79	8.49	2.29	1.88	0.41	0.57	0.24	0.24	0.00
medulla oblongata, newborn, donor10223	10361-105F1	86.45	32.29	4.51	2.78	1.04	0.35	0.00	0.35	0.35	0.00
medulloblastoma cell line:D283 Med	10838-111E1	0.00	56.68	19.04	1.11	0.00	2.66	0.44	0.22	0.22	0.00
medulloblastoma cell line:ONS-76	10759-110E3	0.00	20.66	0.73	0.00	0.00	0.00	0.00	0.00	0.12	0.00
melanoma cell line:COLO 679	10514-107E1	977.62	114.13	216.34	1.58	89.41	3.88	23.14	0.43	3.45	4.31
melanoma cell line:G-361	10465-106H6	194.64	111.03	25.52	1.09	13.03	1.63	2.17	0.00	1.90	1.09
meningioma cell line:HKBMM	10691-109F7	65.13	60.96	31.66	10.49	2.71	0.36	0.54	0.90	0.54	0.54
merkel cell carcinoma cell line:MKL-1	10843-111E6	0.00	61.68	0.00	2.64	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	0.00	55.47	0.26	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal precursor cell - adipose, donor1	11747-123G1	3.22	92.67	41.12	9.21	0.61	3.38	0.31	0.61	0.15	0.31
mesenchymal precursor cell - adipose, donor2	11748-123G2	15.27	64.17	121.07	5.64	3.82	5.27	4.00	0.91	0.55	0.55
mesenchymal precursor cell - adipose, donor3	11749-123G3	26.50	59.22	67.50	9.94	4.14	3.73	0.83	2.07	0.41	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	1.12	37.65	9.83	2.25	0.28	0.56	0.56	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	2.70	36.97	15.98	4.43	0.58	1.35	0.58	0.00	0.00	0.00
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	53.44	36.09	25.68	5.55	5.55	2.78	0.00	0.00	1.39	0.00
mesenchymal precursor cell - cardiac, donor1	11752-123G6	45.48	97.32	186.57	3.95	5.49	7.55	9.61	0.00	1.72	0.34
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.73	58.77	113.52	11.27	1.84	5.18	5.06	0.12	1.15	0.12
mesenchymal precursor cell - cardiac, donor3	11754-123G8	0.66	65.39	18.30	3.85	0.13	0.66	0.27	0.40	0.53	0.00
mesenchymal precursor cell - cardiac, donor4	11755-123G9	1.08	51.99	4.05	4.73	0.00	0.54	0.00	0.00	0.27	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	0.85	68.14	9.96	6.12	0.14	1.28	0.00	0.43	0.71	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	80.03	79.05	51.05	4.94	5.60	2.31	2.63	0.00	0.66	0.33
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	1.11	63.37	17.02	6.37	0.28	1.25	0.14	0.28	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	2.09	43.29	9.77	2.79	0.00	0.35	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	3.27	46.75	21.44	8.17	0.00	1.84	0.20	0.41	0.20	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	31.27	58.59	50.68	6.11	3.59	2.16	1.08	0.72	0.36	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	0.62	24.52	6.10	2.28	0.10	0.31	0.21	0.10	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	5.47	20.75	13.68	3.42	0.68	0.91	0.23	0.68	0.46	0.23
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	6.29	67.55	14.68	5.03	0.00	0.00	0.00	0.42	0.42	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	0.30	34.82	1.20	1.49	0.15	0.15	0.00	0.00	0.30	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	2.19	66.87	50.07	6.30	1.23	3.68	0.70	0.44	0.26	0.09
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	1.10	37.92	23.56	6.26	0.00	1.10	0.74	1.47	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	39.49	38.06	29.76	6.30	2.86	1.72	0.57	1.14	0.29	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	1.26	40.84	2.11	2.53	0.00	0.00	0.00	0.42	0.42	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	11.87	34.71	41.10	5.94	1.37	1.37	0.91	0.46	2.28	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	19.95	40.16	55.25	9.46	1.79	3.58	2.56	1.28	0.26	1.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	18.85	38.22	57.32	8.11	2.36	3.66	2.09	0.26	1.31	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	20.64	34.81	49.60	9.24	1.85	2.16	1.54	1.23	0.31	0.92
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	16.24	41.42	55.07	7.06	3.77	3.53	3.06	0.94	1.18	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	24.37	42.98	54.83	8.46	3.38	3.72	3.05	0.00	0.34	1.02
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	16.90	31.83	49.51	7.86	1.57	4.32	3.54	1.57	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	12.97	32.44	53.75	11.12	3.71	2.78	0.46	0.46	0.46	2.32
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00	48.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	22.78	42.40	59.13	10.09	4.33	4.33	4.04	0.58	0.58	1.15
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	16.51	37.03	59.34	7.81	3.35	3.35	1.56	1.34	0.67	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	18.03	44.95	57.44	8.89	1.68	4.81	1.44	0.48	0.96	0.96
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	27.13	37.40	49.87	5.13	1.47	2.93	3.67	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	21.15	32.22	45.65	8.73	4.03	1.68	3.36	1.01	2.35	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	21.70	36.43	60.18	7.37	3.68	2.05	2.05	0.41	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	15.46	33.51	52.84	9.45	0.43	3.44	0.43	1.29	1.29	0.43
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	16.41	21.88	30.08	5.47	2.73	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	20.66	41.32	30.99	10.33	0.00	0.00	0.00	0.00	5.16	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	16.89	38.65	43.20	8.44	2.92	3.25	2.60	0.65	0.97	0.32
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	21.82	53.83	40.74	5.82	0.00	2.91	2.91	0.00	1.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	24.52	35.18	49.04	7.46	2.67	3.73	2.13	0.53	2.67	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	17.17	26.17	35.16	5.72	3.27	2.45	0.00	1.64	2.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	15.94	35.37	42.76	5.05	2.72	3.11	2.33	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	14.69	37.78	29.38	6.30	6.30	4.20	2.10	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	23.84	31.79	35.76	8.94	1.99	1.99	0.00	0.99	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	19.07	47.67	47.67	0.00	0.00	0.00	0.00	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	18.38	32.02	33.80	10.67	1.19	1.78	1.78	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	10.97	38.99	32.90	6.09	1.22	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	54.10	0.00	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	17.73	34.84	32.30	12.03	1.27	3.80	1.90	0.63	1.90	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	3.45	19.31	28.28	6.21	0.34	1.72	0.34	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	8.60	25.79	17.19	10.75	0.00	0.00	0.00	2.15	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	3.99	23.95	27.94	3.99	3.99	0.00	0.00	3.99	3.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	6.89	20.66	37.88	0.00	3.44	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	2.85	12.63	35.45	4.89	0.41	0.81	1.63	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	2.38	19.86	26.22	6.36	0.00	1.59	2.38	0.00	2.38	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	0.59	11.20	15.33	1.18	0.59	1.18	0.59	0.59	0.59	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	2.18	10.60	12.78	4.05	0.31	1.56	1.25	0.31	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	0.00	14.70	21.39	4.01	0.00	1.34	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	0.00	8.28	3.55	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	0.00	7.70	5.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	0.00	10.33	3.44	0.69	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	0.49	10.89	5.44	0.99	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	0.00	8.97	2.24	1.12	0.00	0.00	0.00	0.00	1.12	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	0.00	12.72	4.45	0.64	0.00	0.64	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	2.01	12.90	8.06	1.21	0.81	0.81	0.81	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	2.18	19.63	10.90	4.36	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	3.80	10.14	6.34	1.27	0.00	1.27	1.27	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	21.24	27.31	83.14	0.61	0.61	4.25	4.25	0.61	0.61	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	27.11	9.04	67.78	0.00	4.52	9.04	4.52	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	19.77	17.30	88.96	5.77	2.47	5.77	3.29	0.82	1.65	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	0.99	12.90	14.68	6.55	0.40	0.60	0.00	0.60	0.20	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	0.97	10.06	7.14	2.92	0.32	0.00	0.32	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	6.11	10.19	8.15	2.04	0.00	1.02	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	20.89	34.82	88.98	9.28	1.55	3.09	4.64	1.55	0.00	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	51.97	52.68	26.70	3.78	2.13	2.83	0.00	0.00	0.00	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	7.65	28.73	19.00	0.23	0.70	0.46	0.70	0.00	0.00	0.23
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	76.92	68.38	47.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	55.69	63.19	26.10	1.34	1.54	0.62	0.62	0.10	0.00	0.00
mesothelioma cell line:Mero-25	10850-111F4	48.57	214.70	174.75	0.23	2.27	2.04	3.86	0.45	2.04	0.45
mesothelioma cell line:Mero-41	10851-111F5	9.05	64.54	19.80	1.71	0.49	0.73	0.00	0.24	0.00	0.00
mesothelioma cell line:Mero-48a	10852-111F6	10.19	33.44	2.88	1.55	0.22	0.22	0.00	0.22	0.00	0.00
mesothelioma cell line:Mero-82	10853-111F7	1191.03	82.52	87.78	0.79	28.65	1.58	4.73	0.00	3.68	2.63
mesothelioma cell line:Mero-83	10854-111F8	21.96	36.94	11.92	1.70	0.51	0.17	0.17	0.00	0.17	0.00
mesothelioma cell line:Mero-84	10855-111F9	6.57	58.39	17.69	2.02	0.51	0.25	0.51	0.25	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	7.87	59.01	37.89	5.18	0.21	1.24	0.21	0.21	0.41	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	2.32	33.63	13.75	3.64	0.50	1.16	0.00	0.17	0.00	0.17
mesothelioma cell line:NCI-H226	10846-111E9	4.34	52.67	23.17	1.09	1.27	0.18	0.18	0.18	0.18	0.00
mesothelioma cell line:NCI-H2452	10848-111F2	52.78	54.15	30.41	5.47	0.85	1.88	0.17	0.68	0.34	0.00
mesothelioma cell line:NCI-H28	10845-111E8	0.51	31.55	4.83	1.78	0.00	1.27	0.00	0.25	0.25	0.00
mesothelioma cell line:No36	10857-111G2	5.87	42.73	14.68	0.98	0.65	0.33	0.33	0.00	0.00	0.00
mesothelioma cell line:ONE58	10858-111G3	73.97	44.17	13.28	2.71	1.08	0.81	0.00	0.27	0.00	0.00
migratory langerhans cells, donor1	11901-125F2	22.07	114.77	3.45	4.03	1.73	0.19	0.00	0.77	0.00	0.00
migratory langerhans cells, donor2	11902-125F3	7.82	81.57	3.30	3.54	0.73	0.12	0.12	0.24	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	15.97	95.48	3.59	3.23	1.08	0.18	0.00	0.00	0.36	0.00
mixed mullerian tumor cell line:HTMMT	10689-109F5	23.83	86.52	53.22	0.65	2.29	2.29	1.31	0.00	0.98	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	26.49	51.08	21.62	3.81	1.06	1.27	3.81	0.00	1.27	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	4.38	198.34	39.62	8.98	0.00	2.07	0.00	1.15	0.69	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	266.98	108.66	31.97	5.90	9.70	0.95	2.09	0.76	1.52	2.28
myelodysplastic syndrome cell line:SKM-1	10772-110F7	0.74	95.35	12.20	11.46	0.18	1.29	0.00	0.37	0.37	0.00
myeloma cell line:PCM6	10474-106I6	1065.82	297.49	322.00	35.98	38.94	15.81	7.91	2.37	3.95	2.37
myxofibrosarcoma cell line:MFH-ino	10600-108E6	2.54	78.12	17.76	2.03	0.00	0.00	1.01	0.00	0.00	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	0.00	29.62	7.65	1.37	0.00	0.98	0.39	0.20	0.20	0.00
nasal epithelial cells, donor1, tech_rep1	12226-129F3	1.34	61.84	13.37	1.67	0.00	0.33	0.11	0.11	0.22	0.00
nasal epithelial cells, donor1, tech_rep2	12226-129F3	2.28	60.30	14.86	1.25	0.07	0.51	0.22	0.15	0.15	0.00
nasal epithelial cells, donor2	12227-129F4	3.31	78.38	28.70	5.52	0.00	1.10	1.10	0.00	0.00	0.00
neuroblastoma cell line:CHP-134	10508-107D4	0.00	150.23	39.34	1.15	0.23	3.68	0.69	0.23	0.23	0.92
neuroblastoma cell line:NB-1	10539-107G8	0.37	61.55	8.42	3.74	0.00	1.31	0.00	0.19	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	2.95	90.47	64.74	0.00	1.27	2.11	0.84	0.00	0.42	0.00
neuroblastoma cell line:NH-12	10555-107I6	0.00	72.12	11.18	0.56	0.19	0.75	0.37	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	0.00	27.28	0.00	0.00	0.00	0.00	0.00	0.00	0.24	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	2.06	75.71	26.77	1.74	0.79	0.79	2.38	0.16	0.79	0.63
neuroectodermal tumor cell line:TASK1	10774-110F9	0.40	72.65	10.06	0.00	0.00	0.00	0.20	0.00	0.00	0.00
neuroepithelioma cell line:SK-N-MC	10728-110A8	0.00	43.23	2.54	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	3.99	52.43	65.48	4.79	1.33	2.66	1.86	0.27	0.00	0.53
neutrophil PMN, donor1	12133-128D9	0.00	59.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	79.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	66.29	9.47	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	0.17	79.49	14.04	15.22	0.17	4.40	0.00	1.18	0.00	0.17
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	0.00	41.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	1.28	46.49	52.90	2.24	0.32	0.64	4.17	0.00	0.64	1.28
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	2261.61	99.59	144.26	4.20	56.49	1.05	17.34	0.26	8.93	5.26
nucleus accumbens, adult, pool1	10037-101F1	14.62	94.86	3.19	1.12	0.09	0.47	0.19	0.00	0.00	0.09
occipital cortex - adult, donor10196	10172-103C1	51.51	86.54	4.12	0.00	0.00	0.00	2.06	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	17.18	56.36	3.76	1.34	0.54	0.00	0.00	0.27	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	20.74	66.60	7.28	1.82	0.36	0.36	0.00	0.00	0.00	0.00
occipital lobe, adult, donor1	10076-102A4	3.67	72.42	0.52	0.00	0.00	0.26	0.00	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	0.00	41.62	0.00	0.00	0.00	0.43	0.00	0.00	0.43	0.00
occipital pole, adult, pool1	10036-101E9	6.47	105.25	1.42	0.79	0.08	0.08	0.00	0.00	0.00	0.00
olfactory region, adult	10195-103E6	15.86	55.60	2.29	0.76	0.00	0.19	0.19	0.19	0.57	0.00
optic nerve, donor1	10277-104E7	10.01	32.02	6.00	0.00	2.00	0.00	0.00	0.00	2.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	16.17	110.60	125.30	4.10	2.05	6.61	1.59	0.34	0.46	0.23
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	35.03	199.90	42.86	4.12	3.98	2.20	0.41	0.27	0.27	0.69
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	67.73	70.10	36.07	4.57	2.54	1.19	0.00	0.17	0.51	0.68
oral squamous cell carcinoma cell line:SAS	10544-107H4	7.39	102.34	27.38	4.62	0.46	1.50	0.00	0.35	0.12	0.35
osteoclastoma cell line:Hs 706.T	10704-109H2	6.17	68.20	43.21	6.76	0.00	4.41	0.88	0.00	0.59	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	58.86	216.77	77.55	10.28	5.61	4.67	0.93	0.93	0.00	0.93
osteosarcoma cell line:HS-Os-1	10558-107I9	1.27	114.30	84.61	5.30	0.21	5.09	1.06	0.00	0.00	0.21
ovary, adult, pool1	10020-101D2	17.03	28.13	7.95	2.45	0.44	0.26	0.17	0.17	0.17	0.17
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	4.03	53.53	13.20	3.85	0.55	2.20	0.18	0.00	0.55	0.18
pancreas, adult, donor1	10049-101G4	8.47	44.21	0.94	2.82	0.00	0.94	0.00	0.00	1.88	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	0.56	43.89	10.62	0.84	0.28	0.28	0.00	0.00	0.28	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	39.01	60.31	20.27	5.28	1.70	0.51	1.02	1.19	0.34	0.51
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	17.88	112.10	29.97	9.11	0.00	2.15	0.33	1.16	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	11.81	104.79	2.38	0.92	0.46	0.09	0.09	0.00	0.18	0.00
parietal cortex, adult, donor10258	10373-105G4	13.21	55.78	0.00	2.20	0.00	0.00	0.00	0.73	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	41.38	63.01	4.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	17.10	59.57	1.71	1.14	0.57	0.29	0.00	0.00	0.29	0.00
parietal lobe, adult, pool1	10034-101E7	9.78	114.03	1.85	1.50	0.70	0.09	0.00	0.09	0.00	0.09
parietal lobe, fetal, donor1	10072-101I9	0.00	45.58	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	47.11	61.69	4.86	1.12	0.00	0.00	0.37	0.00	0.00	0.00
parotid gland, adult	10199-103F1	20.35	46.87	1.85	3.08	0.62	0.62	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	26.86	30.62	8.06	1.07	2.15	1.61	0.54	0.00	1.07	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	0.00	35.51	0.19	0.19	0.00	0.19	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	181.83	167.99	87.56	8.01	8.60	5.68	1.89	0.58	1.17	0.87
pineal gland - adult, donor10196	10179-103C8	10.97	60.63	5.81	3.87	0.00	0.65	0.00	0.00	0.00	0.00
pineal gland, adult, donor10252	10160-103A7	13.03	84.09	4.74	2.96	1.18	0.00	0.00	0.59	0.00	0.00
pineal gland, adult, donor10258	10377-105G8	5.64	43.90	1.88	1.25	1.88	0.63	0.63	0.00	0.63	0.00
pituitary gland - adult, donor10196	10180-103C9	35.41	69.81	6.07	2.02	1.01	1.01	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10252	10162-103A9	54.72	75.57	7.82	3.65	0.52	0.52	0.52	0.52	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	6.81	34.05	0.85	0.85	0.00	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	203.18	34.40	81.81	4.09	3.44	3.55	22.68	0.22	0.97	0.75
plasma cell leukemia cell line:ARH-77	10840-111E3	90.98	104.62	38.80	7.15	5.96	4.50	0.93	1.85	0.66	0.53
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	1.71	19.14	2.02	2.02	0.47	0.47	0.00	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	15.75	99.06	3.36	1.64	0.43	0.34	0.09	0.09	0.17	0.09
postcentral gyrus, adult, pool1	10032-101E5	8.89	101.21	1.39	0.87	0.17	0.26	0.00	0.00	0.09	0.00
promyelocytes/myelocytes PMC, donor1	12132-128D8	0.00	31.37	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	0.00	49.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	0.00	46.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	9.76	87.54	9.47	2.33	0.29	0.87	0.73	0.15	0.29	0.15
prostate cancer cell line:PC-3	10439-106E7	1.45	62.98	6.17	1.63	0.73	0.18	0.36	0.00	0.00	0.00
prostate, adult, pool1	10022-101D4	38.82	25.94	3.81	2.00	0.45	0.09	0.00	0.00	0.18	0.18
putamen, adult, donor10196	10176-103C5	45.32	77.43	2.60	0.71	0.94	0.00	0.71	0.00	0.71	0.00
putamen, adult, donor10252	10152-102I8	31.37	31.37	0.00	1.96	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	16.39	71.03	5.46	5.46	0.00	1.09	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep2	10372-105G3	19.81	53.40	1.21	0.72	0.24	0.00	0.00	0.00	0.24	0.00
putamen, newborn, donor10223	10365-105F5	74.22	50.23	8.25	1.50	1.50	0.00	0.75	0.00	0.00	0.00
rectal cancer cell line:TT1TKB	10469-106I1	14.84	87.86	67.21	2.91	0.29	2.04	0.58	0.58	0.29	0.00
rectum, fetal, donor1	10067-101I4	26.43	23.65	4.17	1.39	0.00	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	0.00	19.50	0.64	1.06	0.00	0.21	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	30.65	24.85	13.25	2.07	1.66	1.24	0.00	0.83	0.41	0.00
retina, adult, pool1	10030-101E3	67.79	49.00	19.08	4.87	3.78	0.50	0.70	0.60	0.10	0.30
retinoblastoma cell line:Y79	10475-106I7	0.00	58.46	2.34	1.30	0.00	0.52	0.00	0.00	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	18.57	110.78	8.11	0.49	0.86	0.37	0.74	0.12	0.12	0.37
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	1.69	60.74	59.05	0.28	0.84	0.84	1.69	0.00	0.56	0.28
sacrococcigeal teratoma cell line:HTST	10695-109G2	11.37	39.41	55.32	6.06	0.76	4.55	0.76	0.00	0.00	2.27
salivary acinar cells, donor1	11771-123I7	0.97	29.62	4.05	3.40	0.00	0.49	0.00	0.16	0.00	0.00
salivary acinar cells, donor2	11772-123I8	0.14	20.65	1.24	0.00	0.14	0.00	0.00	0.00	0.28	0.00
salivary acinar cells, donor3	11773-123I9	0.00	20.52	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
salivary gland, adult, pool1	10093-102C3	26.88	66.35	1.14	2.86	0.00	0.00	0.00	0.00	0.00	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	11.38	136.25	82.04	9.27	1.52	7.50	0.67	0.51	0.67	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	9.87	128.13	77.35	9.52	1.18	6.47	1.06	0.47	0.35	0.47
seminal vesicle, adult	10201-103F3	12.70	26.45	3.17	0.00	0.53	0.00	0.00	0.00	1.06	0.00
serous adenocarcinoma cell line:JHOS-2	10639-108I9	15.06	47.37	19.92	7.77	0.97	1.70	1.21	1.21	0.73	0.24
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	2.77	35.98	14.85	6.04	0.25	0.75	0.25	0.50	0.00	0.00
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	0.00	38.13	3.01	1.00	0.00	0.00	0.00	0.00	0.00	0.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	28.61	126.26	78.71	1.48	1.88	3.36	7.25	0.40	0.81	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	1131.36	122.24	44.43	8.95	3.21	6.08	0.55	1.33	0.99	0.11
signet ring carcinoma cell line:NUGC-4	10483-107A6	4.64	30.19	1.03	1.55	0.26	0.13	0.00	0.00	0.00	0.00
skeletal muscle - soleus muscle, donor1	10282-104F3	33.34	31.21	13.48	1.42	0.00	2.84	3.55	0.00	0.71	0.00
skeletal muscle, adult, pool1	10023-101D5	68.12	22.43	10.55	2.04	0.60	0.84	0.96	0.12	0.72	0.12
skeletal muscle, fetal, donor1	10066-101I3	19.10	18.09	2.01	1.01	1.01	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	0.00	6.79	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
skin, fetal, donor1	10065-101I2	8.84	21.46	5.68	1.89	1.26	0.63	0.63	0.00	0.63	0.00
small cell cervical cancer cell line:HCSC-1	10800-110I8	2.00	48.36	6.00	1.00	0.00	0.00	0.67	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	0.00	54.22	7.25	1.26	0.00	0.32	0.00	0.63	0.32	0.00
small cell lung carcinoma cell line:DMS 144	10841-111E4	0.00	60.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	35.11	131.70	57.69	9.23	3.79	7.42	2.80	1.48	0.33	0.33
small cell lung carcinoma cell line:NCI-H82	10842-111E5	0.00	52.12	0.48	0.16	0.00	0.16	0.00	0.00	0.48	0.00
small cell lung carcinoma cell line:WA-hT	10562-108A4	49.90	99.37	42.93	8.28	1.09	7.41	1.53	0.22	0.22	0.44
small intestine, adult, pool1	10024-101D6	46.58	37.39	6.57	2.03	1.91	0.48	0.60	0.00	0.36	0.48
small intestine, fetal, donor1	10064-101I1	39.07	28.50	7.86	2.70	2.21	1.23	0.98	0.00	0.49	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	3.08	95.91	9.23	6.15	0.00	2.05	0.00	0.51	0.51	0.00
smooth muscle, adult, pool1	10048-101G3	17.32	26.62	4.39	2.58	0.26	0.78	0.00	0.26	0.00	0.26
somatostatinoma cell line:QGP-1	10781-110G7	11.79	98.63	24.93	3.48	2.68	1.34	0.80	0.80	0.00	0.27
spinal cord - adult, donor10196	10181-103D1	44.05	24.78	4.82	1.15	0.46	0.46	0.46	0.00	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	15.77	27.20	5.13	6.70	0.79	0.39	0.00	0.79	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	16.60	24.90	2.08	3.46	0.69	0.00	0.00	0.69	0.00	0.00
spinal cord, fetal, donor1	10056-101H2	10.37	36.59	1.83	1.22	0.00	0.61	0.00	0.61	0.61	0.00
spinal cord, newborn, donor10223	10359-105E8	58.78	56.94	10.10	2.30	0.00	0.92	0.00	0.00	0.46	0.00
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	2.24	62.58	53.47	9.71	0.45	5.97	1.64	0.75	0.45	0.15
spleen, adult, pool1	10025-101D7	155.51	56.83	13.66	7.82	5.73	0.44	0.11	0.33	0.22	0.55
spleen, fetal, pool1	10044-101F8	109.25	59.75	17.40	7.95	4.21	1.11	0.56	0.56	0.08	0.87
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	22.36	61.38	18.94	3.00	2.07	1.14	0.31	0.21	0.10	0.10
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	95.89	77.66	43.86	9.49	6.08	3.42	1.14	1.52	0.19	0.38
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	10.83	91.91	12.93	1.05	0.70	1.05	0.35	0.00	0.35	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	10.95	121.97	49.26	7.43	0.78	4.69	0.39	1.56	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	11.26	227.59	70.91	11.26	0.56	6.64	0.79	1.91	0.11	0.11
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	0.85	30.08	0.85	0.85	0.00	0.00	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	0.00	33.42	5.08	2.96	0.00	0.42	0.00	0.42	0.00	0.00
stomach, fetal, donor1	10062-101H8	21.36	25.63	5.34	1.07	0.00	0.00	1.07	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	16.52	34.18	3.99	1.14	0.00	0.00	0.00	0.00	0.57	0.00
substantia nigra - adult, donor10196	10178-103C7	54.27	54.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	19.32	24.51	6.85	5.61	0.42	0.42	0.21	0.21	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	18.62	52.76	0.52	1.55	0.00	1.03	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	41.69	27.56	1.41	2.12	0.71	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	0.00	58.46	0.00	0.23	0.00	0.00	0.00	0.00	0.23	0.00
temporal lobe, adult, pool1	10031-101E4	7.97	92.23	2.71	1.02	0.00	0.17	0.17	0.17	0.25	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	0.71	56.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	0.44	51.43	1.32	0.44	0.00	0.00	0.00	0.00	0.44	0.00
tenocyte, donor1	11763-123H8	17.11	33.86	5.24	3.84	0.70	0.00	0.70	0.35	0.35	0.00
tenocyte, donor2	11765-123I1	29.38	17.93	9.54	4.58	1.14	0.38	0.00	0.00	0.00	0.38
tenocyte, donor3	11768-123I4	1.85	31.51	4.08	7.78	0.37	0.37	0.00	0.37	0.37	0.00
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	8.50	79.20	33.31	0.51	2.72	0.68	0.85	0.00	0.51	0.34
teratocarcinoma cell line:NCR-G1	10798-110I6	0.77	123.78	12.49	0.00	0.31	0.62	0.00	0.00	1.39	0.00
teratocarcinoma cell line:PA-1	10807-111A6	0.31	70.82	6.66	0.93	0.00	0.15	0.00	0.00	0.31	0.00
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	29.07	112.73	140.28	0.76	8.76	2.92	10.79	0.00	1.27	2.54
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	220.47	239.38	242.79	0.00	26.85	4.16	20.80	0.00	1.89	1.89
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	9.38	69.91	118.99	0.76	4.80	2.62	12.00	0.11	0.87	1.09
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	41.04	136.47	185.32	0.33	6.51	4.56	40.71	0.00	3.26	0.98
testis, adult, pool1	10026-101D8	7.52	125.73	4.72	2.15	0.32	0.11	0.21	0.21	3.11	0.00
testis, adult, pool2	10096-102C6	4.96	181.79	1.80	0.45	0.00	0.45	0.00	0.00	0.90	0.45
thalamus - adult, donor10196	10168-103B6	87.21	43.06	3.31	2.21	1.10	1.10	1.10	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	22.04	32.82	3.44	2.19	1.09	0.16	0.00	0.16	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	21.55	61.58	0.00	1.54	0.00	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.86	29.48	0.99	0.66	0.16	0.16	0.00	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	55.23	73.64	3.45	1.73	1.73	0.58	0.58	0.00	0.58	0.00
throat, adult	10209-103G2	35.70	28.96	6.24	2.00	0.25	0.50	0.00	0.50	0.75	0.00
throat, fetal, donor1	10061-101H7	7.62	23.16	5.48	1.22	0.00	0.61	0.00	0.30	0.00	0.00
thymic carcinoma cell line:Ty-82	10803-111A2	1.19	79.49	1.19	0.20	0.20	0.00	0.00	0.00	0.40	0.00
thymus, adult, pool1	10027-101D9	40.66	59.55	5.17	1.59	1.49	0.70	0.10	0.10	0.10	0.10
thymus, fetal, pool1	10043-101F7	35.64	49.67	6.86	1.97	0.83	0.73	0.52	0.00	0.10	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	1.33	75.92	17.82	7.71	0.00	1.20	0.13	0.66	0.93	0.00
thyroid carcinoma cell line:TCO-1	10783-110G9	13.55	101.28	36.18	2.93	0.98	1.12	1.12	0.14	0.42	0.42
thyroid, adult, pool1	10028-101E1	764.33	79.04	10.26	4.20	3.64	0.47	2.61	0.28	1.77	0.84
thyroid, fetal, donor1	10060-101H6	11.34	34.54	5.54	1.32	0.79	0.53	0.53	0.53	0.26	0.00
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	30.80	3.08	3.08	0.00	0.00	0.00	0.00	0.00	0.00
tongue, adult	10203-103F5	40.70	30.70	7.91	1.16	0.23	0.70	0.00	0.00	0.70	0.00
tongue, fetal, donor1	10059-101H5	19.31	15.76	18.52	1.97	0.00	0.79	2.36	0.00	0.00	0.00
tonsil, adult, pool1	10047-101G2	42.88	65.62	8.31	4.41	1.80	0.60	0.30	0.30	0.40	0.10
trachea, adult, pool1	10029-101E2	134.15	54.72	8.92	4.74	1.47	1.15	0.25	0.41	0.41	0.16
trachea, fetal, donor1	10058-101H4	27.70	18.85	9.62	2.31	0.77	0.77	0.00	0.00	0.00	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	7.79	77.23	36.14	7.44	1.77	1.06	0.00	0.00	0.00	0.71
transitional-cell carcinoma cell line:5637	10418-106C4	37.89	139.51	68.90	6.28	3.75	3.65	1.62	0.51	0.20	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	21.62	146.66	146.03	3.29	2.66	7.99	3.92	0.31	1.57	0.31
tridermal teratoma cell line:HGRT	10694-109G1	0.00	30.44	9.51	0.00	0.00	0.00	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	37.75	143.82	105.73	4.99	1.52	6.52	1.78	0.51	0.68	0.51
umbilical cord, fetal, donor1	10057-101H3	8.35	22.95	4.17	0.00	0.00	0.00	2.09	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	43.34	47.26	6.65	5.29	0.17	0.68	0.00	0.00	0.00	0.00
uterus, fetal, donor1	10055-101H1	5.63	22.52	2.05	3.07	0.00	0.00	0.51	0.00	0.51	0.00
vagina, adult	10204-103F6	17.45	20.68	12.28	5.82	0.65	0.00	0.00	1.29	0.00	0.00
vein, adult	10191-103E2	41.21	28.06	8.55	7.01	1.10	0.88	0.66	0.00	0.22	0.00
xeroderma pigentosum b cell line:XPL 17	10563-108A5	187.99	92.66	19.49	4.54	6.41	2.40	2.40	0.27	0.27	0.00